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Regulation of renal sodium (Na+) excretion is crucial for the maintenance of extracellular salt 
and volume homeostasis and thus for blood pressure control. The epithelial sodium channel 
(ENaC) is composed of three subunits; α, β and γ; each subunit contains two transmembrane 
domains where both C- and N-terminal domains are cytoplasmic and allow interaction with 
regulatory proteins. For its sodium regulating properties, ENaC is principally present in the 
kidney collecting duct, reabsorbing ions from the urine to prevent unnecessary loss of salt and 
hence, water. This makes the channel vital for maintaining ECF homeostasis and consequently 
blood pressure. Channel activity is highly dependent on the density at the apical membrane, 
where sodium current is proportional to channel number. Dysregulation of ENaC or its 
associated trafficking proteins can lead to an array of problems which disrupt sodium 
homeostasis, leading to hypo/hypertension. 
 
Although extensive research has gone into unravelling the downregulation of ENaC by 
endocytosis, there has been significantly less research into its exocytosis. The p11 protein is 
known to promote exocytosis of a number of other membrane channels. We hypothesized that 
addition of p11 would cause an increase ENaC trafficking, and subsequently increase the 
amiloride sensitive current in Xenopus laevis oocytes. 
 
Previous research at the University of Otago confirmed the presence of an interaction between 
p11 and ENaC, and also identified that p11 is expressed endogenously within epithelial cells. To 
confirm a functional consequence of this interaction electrophysiological experiments were 





alone or together with mRNA coding for p11. Two electrode voltage clamp was carried out to 
measure ENaC current. Results from my experiments showed an increase in the amiloride 
sensitive current in the presence of p11 at both 0.75ng (12%) and 1.50ng (17%) p11 
concentrations, however the results were insignificant for both 0.75ng (p=0.46) and 1.5ng 
(p=0.24). Preliminary results from the Condliffe lab show increased amiloride sensitive current 
for oocytes co-expressing ENaC + p11 as compared to oocytes expressing ENaC alone, 
indicating, that the presence of p11 promotes ENaC membrane insertion. Proteins from the 
oocytes were also used for western blotting to identify p11 within the oocytes, however, 
inconclusive results were obtained. Second, we wanted to determine if the amiloride sensitive 
current would reverse upon silencing of p11. Fisher rat thyroid epithelia were transfected with 
plasmids encoding ENaC subunits + si-p11 RNA, and their resistance and amiloride sensitive 
currents recorded using an Ussing chamber apparatus. Results show a significant decrease 
(average of 75%) (p=0.04) in the amiloride sensitive current for ENaC + si-p11, when 
compared to control (ENaC + si-control). 
 
Overall, it is confirmed that p11 interacts with ENaC. Furthermore, it is highly likely that p11 
plays a role in aiding the exocytosis of ENaC, as concluded from both the overexpression and 
knockdown experiments. A significant lack of any previous research on the interaction between 
ENaC and p11 contributed to the difficulty of this project, however, the resultant information 
significantly aids our understanding of the exocytic process of ENaC and the individual proteins 
involved, such as p11. The real-world applications of this information span across a wide 
spectrum including therapeutic approaches for both hyper and hypotension which are large 
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1- Introduction  
1.1- ENaC 
1.1.1- ENaC Function 
Sodium is a principal ion present throughout the body, and is essential for everything from neural 
function to regulating blood pressure. Therefore, sodium balance is vital for proper function of 
cells. Present in the late distal tubule and cortical collecting duct of the nephron, the epithelial 
sodium channel (ENaC) plays a critical role in regulating sodium reabsorption (Figure 1.1). As a 
result, ENaC plays a role in determining the blood volume and pressure. Because it is the rate 
limiting factor for Na+ reabsorption in the distal kidney, ENaC is highly regulated by a number 
of hormones which work together with cellular proteins to bring about control of sodium levels 














Figure 1.1. The epithelial sodium channel reabsorbs sodium from the filtrate. ENaC reabsorbs 
sodium from the nephron lumen, due to the electrostatic gradient generated by the Na/K ATPase in the 
basal membrane. The driving force allows for the passive flow of sodium through ENaC into the cell and 






1.1.2- Structure and Location 
The amiloride-sensitive epithelial sodium channel (ENaC) is a transmembrane channel, 
composed of three subunits; α, β and γ (Canessa et al, 1994), see Figure 1.2. Each subunit 
contains two transmembrane domains where both C- and N-termini are located in the cytoplasm 
and play a role in channel regulation through interaction with regulatory proteins (Goulet et al, 
1998). The subunits are synthesized from individual genes (SCNN1A, SCNN1B and SCNN1G), 
that come together in the endoplasmic reticulum (ER) post translationally to form a functional 
channel (reviewd by Hanukoglu & Hanukoglu, 2016). Once assembled, the channel undergoes 
post translational modifications in the Golgi and is transported to the apical membrane via 
several interacting proteins, where it becomes functional and carries out its role in sodium 
homeostasis (from within the kidney nephron). As a channel, selectivity for sodium ions arises 
Figure 1.2. Membrane topology and stoichiometry of ENaC. The three subunits aggregate in the 
orientation above to form a functional pore within the cell surface membrane, allowing the passive and 




due to certain hydrophobic amino acid residues within the α subunit, specifically the C-terminus, 
which surrounds the pore-forming second transmembrane domain (Sheng et al, 2000). 
In the kidney, ENaC is principally present in the apical membrane of the collecting duct cells, 
but also the late distal convoluted tubule. Here, it reabsorbs ions from the filtrate to prevent 
unnecessary loss of salt and hence, water (Pearce et al, 2014), however, the presence of ENaC is 
not confined to the nephron. The channel is also expressed in other epithelia such as distal colon, 
pulmonary epithelia and reproductive tracts (Sheng et al, 2000). In the lungs, ENaC helps to 
maintain the pulmonary surfactant which is necessary to prevent drying of the air-alveolar 
interface. The lack of proper function here can be terminal, as defined by ENaC knockout 
experiments in mice, that led to an inability to clear fluid from the lungs after birth (Hummler et 
al, 1996). This further underlines the clinical significance of ENaC function in pulmonary 
epithelia for cystic fibrosis (CF). CF is a disease caused by cystic fibrosis transmembrane 
conductance regulator (CFTR) gene dysfunction, reducing functional channels at the membrane. 
The lack of Cl- secretion reduces the subsequent water secretion, leading to increased mucus 
viscosity, resulting in vulnerability to bacterial infections, and a reduced lifespan (Donaldson et 
al, 2006). 
1.1.3- ENaC Properties 
ENaC was first identified to be related to a group of genes expressed in Caenorhabditis elegans 
named Degenerins due to mutations found in them which led to neural degeneration (Canessa et 
al, 1993). Further identification of similar genes led to identification of the ENaC/Degenerin 
family which includes peptide gated, amide gated (FaNaC) and multiple proton gated ion 
channels (ASICs) (reviewed in Kellenberger & Schild, 2002). ENaC is expressed in most sodium 




epithelia or the neuronal system. Biophysically, ENaC is characterized by 4 primary features; 
high sodium selectivity, low unitary conductance, long opening and closing times and a high 
sensitivity to inhibition by amiloride (Horisberger, 1998).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
1.1.3.1- Sodium Selectivity 
Previous literature has identified specific amino acid residues within the ENaC subunits which 
provide the sodium selectivity. For each subunit, the two transmembrane domains (termed M1 
and M2) contain between them two hydrophobic regions (termed H1 and H2). The hydrophobic 
region immediately preceding the M2 is also present within the phospholipid bilayer/ cell 
membrane. This pre M2 hydrophobic region of each subunit is thought to contribute to the 
selectivity of the conducting pore (Ji et al, 2004). Experiments by Kellenberger et al (2001) build 
on this, showing mutations in the pre M2 segment (αS589) alters the ion selectivity, making the 
channel additionally permeable to potassium ions. Furthermore, it was proposed that the 
mutation specifically increases the size of the pore at the selectivity filter, and due to the 
increased ability of larger ions to flow, the unitary conductance of small cations such as Na+ 
decreases. These findings show the critical role of the pore size for the selectivity properties of 
ENaC (Kellenburger et al, 2001). This was challenged by Sheng et al (2000) who mutated all 24 
amino acids within the pore region of the α subunit to cysteine in individual experiments. The 
only significant results were from cysteine substitution within the carboxyl terminal domain, 
rather than pre M2 regions, contradicting the findings of Kellenburger et al (2001). The 
substitutions resulted in changes of cation selectivity and the mutant channels became 




1.1.3.2- Amiloride Sensitivity 
A defining characteristic of ENaC is brought about as a result of its interaction with amiloride. 
Amiloride is a relatively small molecule of pyrazine with a substituted guanidium side chain, and 
acts to rapidly block the channel pore when applied to the apical side of the epithelia containing 
ENaC. The rapid block inhibits Na+ flow through the channel, reducing ENaC current produced. 
As a result, application of amiloride in an experimental condition allows us to identify the ENaC 
specific current, A.K.A. the amiloride sensitive current. Although a majority of the documented 
tests proclaim amiloride only functions when applied apically (Palmer & Frindt, 1986), there 
have been instances of blocking when applied cytoplasmically in high enough concentrations 
(Gogelein & Greger, 1986). In vivo, most of the amiloride sensitive transport has been 
documented in the outer medullary collecting duct, the distal convoluted tubule and the 
connecting tubule, where the concentration required for 50% blockage of Na+ transport was 
between 0.1 and 1 µM (Kleyman & Cragoe, 1988). Amiloride is a high affinity blocker of ENaC, 
however, experiments have found that it is affected by other factors such the transmembrane 
voltage, the extracellular pH and also the extracellular Na+ concentration. Because amiloride is a 
weak base, its slightly positive charge contributes to its attraction to and interaction with ENaC 
(Palmer, 1984). 
1.1.4- ENaC Trafficking 
Excluding expression itself, the lifespan of an epithelial protein such as ENaC consist of four 
major segments; apical delivery (exocytosis), internalization (endocytosis), recycling and 




1.1.4.1- ENaC Exocytosis 
The exocytic mechanism of ENaC is poorly understood, however, the basics of synthesis and 
processing are established. Exocytosis of ENaC requires its translocation from the ER to the 
apical cell surface. This requires protein trafficking; the process of transporting a protein from its 
location of production or temporary storage, to a different target site. Once synthesized and 
processed by the ER, ENaC is transported to and processed by the Golgi complex, starting at the 
cis and ending at the trans Golgi network (Adams et al, 1997). Post Golgi, the mechanistic 
details of trafficking of ENaC is lacking in evidence and corroboration, however, it is likely 
ENaC follows a pathway common to most epithelial channels as described in the following 
sentences. At the trans-Golgi network, the channel is sorted into apical bound clathrin coated 
vesicles and then trafficked to the apical membrane (Folsch, 2008) either directly or through 
apical recycling/ early endosomes (Grant & Donaldson, 2009). The process also recruits multiple 
accessory proteins such as Rab or motor proteins (Jing & Prekeris, 2009) to facilitate the 
physical trafficking. The vesicle cargo is transported using motor proteins such as kinesin and 
non-muscle myosin (Folsch, 2008), which travel along the actin tracks to the apical membrane 
(Eitzen, 2003), where eventually, fusion is promoted by SNARE proteins such as syntaxin, 
VAMP and SNAP (Duman & Forte, 2003). The interaction between ENaC and syntaxins was 
investigated by Saxena et al (1999) and Condliffe et al (2003, 2004), who identified 
overexpression of both syntaxin1A and 3 increased ENaC expression at the cell surface. 
However, ENaC co-expressed with syntaxin1A reduced the amiloride sensitive current when 
compared to syntaxin 3 which increased it, concluding that functional expression is isoform 
specific (Saxena et al, 1999). Another potential accessory protein in ENaC exocytic trafficking 




such as CFTR and ASICs, and is therefore proposed to also interact with ENaC for apical 
translocation, which is further discussed in section 1.2.  
Although these are basic understandings of the exocytosis pathway, for the ENaC exocytic 
trafficking mechanism, there is a great lack in knowledge. Previously conducted research leads 
to both uncertain and contradictory findings. For example, it is accepted that ENaC matures 
within the Golgi complex (Rotin et al, 2001), however there is also evidence of ENaC 
populations which bypass the Golgi (Hughey et al, 2004). Furthermore, there is evidence for 
both lipid raft based and raft free trafficking, and work by Hill et al (2002) validates that 
depletion of cholesterol to disrupt lipid rafts results in failure of ENaC delivery to the apical 
membrane (Hill et al, 2002). Conversely, analogous studies have also found little to no change in 
ENaC regulation when lipid rafts were disrupted (West & Blazer, 2005). It is evident from the 
current understanding, that the exocytosis pathway for ENaC is severely unexplored and requires 
further research. 
1.1.4.2- ENaC Endocytosis 
With a half-life of 20 to 30 minutes, ENaC is not a long-lived protein (Staub et al, 1997). Its 
internalisation is commonly in response to high sodium concentrations in the ECF which can 
lead to elevated blood pressure, and therefore, to reduce sodium reabsorption, the ENaC channels 
are down-regulated. ENaC is internalized from the membrane by the clathrin mediated pathway 
(Wang et al, 2006; Hill et al, 2007), which is mediated predominantly by Nedd4-2 ubiquitination 
(Staruschenko et al, 2005). Nedd4-2 is an E3 ubiquitin ligase which uses its WW domains to 
bind to the internalization signals PPxY located in the ENaC C-terminal domains. Once attached, 
it catalyzes the addition of ubiquitin molecules onto ENaC, which acts as an internalisation 




found that the extent of ubiquitination, whether it may be mono- or poly-ubiquitination, plays a 
role in determining between recycling and degradation (Li et al, 2003). Furthermore, the 
internalization signal PPxY overlaps with another internalization signal Yxxφ which is 
recognized by the adaptor protein 2 complex (AP-2) and has been shown to interact with ENaC 
also (Staruschenko et al, 2005), suggesting there is more than one outcome for the same signal. 
Once ubiquitinated, epsin binds to ubiquitinated ENaC and to clathrin adaptor proteins (Wang et 
al, 2006). Epsin recruitment is regulated by the phospholipid PIP2, which then initiates budding 
of clathrin coated vesicles by interacting with synaptojanin-1, which is a constituent of the 
vesicles (Cremona et al, 1999). Validation of this theory is provided by Weixel et al (2007), who 
demonstrated that stimulation of PIP2 production using PIP5-K results in a decrease of surface 
ENaC expression (Weixel et al, 2007). Furthermore, Wang et al. (2006), identified the presence 
of ENaC in clathrin vesicles that were delivered to the early endosome by co-expressing ENaC 
and epsin to increase downregulation and evaluating the purified homogenate for ENaC presence 
in clathrin coated vesicles (Wang et al, 2006). When comparing the knowledge around 
endocytosis of ENaC to the exocytosis, there is a clear gap in knowledge around exocytosis. 
Although we don’t know much about the proteins involved for the exocytotic process of ENaC, 
we do have knowledge of similar epithelial channels such as CFTR and NKCC2, which provide 
a starting place in the research, see section 1.2. 
1.1.5- ENaC Regulation 
Absorption of salt and water is carefully balanced with its excretion in order to maintain 
homeostasis of blood pressure. To achieve accurate compensation, sodium reabsorption in the 
kidney has to adapt to the varying ECF ionic environment. As a consequence, because sodium is 




blood pressure) is achievable through regulation of the channel population present in the apical 
membrane of the nephron (Baker, 2000). 
The rate of sodium reabsorption via ENaC depends primarily on two factors, firstly; the open 
probability of the channel; which is determined by the proportion of time that the channel is in 
the open state, and secondly; the total number of channels present in the apical membrane, where 
the rate of transport is proportional to both of these factors. Open probability is often regulated 
through proteolytic cleavage or phosphorylation, but the number of channels is dependent on the 
rate of insertion and removal from the apical membrane (Eaton et al, 2010). Changes in the 
channel population is mediated chiefly by the mineralocorticoid hormone: aldosterone, however, 
regulation is also influenced by hormones such as vasopressin and insulin (reviewed in Garty & 
Palmer, 1997).  
1.1.5.1- Renin-Angiotensin System 
The renin-angiotensin-aldosterone system is the major sodium homeostasis regulator in the body. 
Several hormones work co-dependently to carry out the task of controlling blood pressure, 
sodium and water levels (Zhang et al, 2017). Initiating in the kidney, lowered blood pressure and 
altered ECF concentration cause the release of renin into the blood. Acting as an enzyme, renin 
catalyzes the conversion of angiotensinogen from the liver into angiotensin 1. As angiotensin 1 
circulates the blood system, it is converted to angiotensin 2 by the angiotensin converting 
enzyme (ACE) present particularly in pulmonary capillaries. Angiotensin 2 then acts to stimulate 
the adrenal glands, causing the release of aldosterone. Simultaneously, angiotensin 2 also causes 





Aldosterone, released from the adrenal glands, acts through the mineralocorticoid receptor of 
cells. Here, aldosterone alters transcription of genes including; serum and glucocorticoid-
regulated kinase 1 (SGK1) and glucocorticoid induced leucine zipper-1 (GILZ1) (reviewed in 
Soundararajan et al, 2012), which promote an increase in synthesis and apical delivery of ENaC. 
Therefore, aldosterone regulates ENaC by promoting gene transcription and translation of ENaC 
subunits, effectively increasing production and activity of ENaC (Chen et al, 2015). Aldosterone 
has been identified to elicit a heterogenous response in the renal collecting duct (Garty & Palmer, 
1997), comprised of 3 central outcomes; an increase specifically in the α subunit of ENaC, 
increasing overall ENaC present at the apical membrane and inducing alterations in the 
molecular weight of the γ subunit (Masilamani et al, 1999). The shift in molecular weight of the 
γ subunit is most likely due to proteolytic cleavage by serine proteases. This is supported by 
Chraibi et al. (1998) who identified an increase in ENaC open probability when a protease was 
introduced to the epithelia. The protease used was trypsin, which induced a 20-fold increase in 
ENaC current. Furthermore, an antibody binding to a FLAG epitope was used to confirm the 
increased current was not accompanied by an increase in cell density at the surface (Chraibi et al, 
1998). Additionally, aldosterone has a confirmed effect on increasing the serine protease activity 
of adenylyl cyclase associated protein-1 (CAP1) (Vallet et al, 1997). Due to this, it is highly 
likely that the shift in molecular weight of the γ subunit induced by aldosterone is a result of 
CAP1 cleavage, ultimately increasing open probability. Aldosterone also stimulates the 
activation of SGK1 to inhibit Nedd4-2-mediated endocytosis of ENaC. Overall, aldosterone 




of sodium reabsorption (Kemendy et al, 1992). The ENaC activation from proteolytic cleavage is 
elaborated in section 1.1.5.5. 
1.1.5.3- Vasopressin 
Vasopressin is an antidiuretic hormone, and therefore incorporates ENaC into its mode of action, 
to increase both water and sodium reabsorption. The vasopressin itself binds to the V2 receptor 
at the basal surface of epithelial cells, causing subsequent activation of a stimulatory G-protein 
and adenylate cyclase, which then catalyses ATP into cAMP (Marunaka et al, 1991). cAMP is 
central to this reaction, causing a downstream signal amplification via protein kinase A (PKA) 
and eventually resulting in increased ENaC density at the cell surface membrane. Although the 
effects of vasopressin are synergistic with aldosterone, instead of being stimulated by a 
decreased sodium levels (such as aldosterone), vasopressin is stimulated by decreased 
osmolarity/ increased osmolality (Bankir et al, 2010). Vasopressin lacks the transcriptional 
effects of aldosterone and hence, the response time for vasopressin is much shorter than 
aldosterone. Instead, vasopressin works through increasing the density of ENaC at the apical 
surface via increased (ENaC-storing) vesicle fusion (Snyder, 2004). This is corroborated by 
Butterworth et al. (2004), who used polarized mouse cortical collecting duct epithelia to show 
that stimulation of cAMP leads to an 83% increase in ENaC current, with cell surface 
biotinylation to confirm an increased channel number at the apical membrane (Butterworth et al, 
2004). Furthermore, due to its reliance on the intracellular pool of vesicle contained channels, 
studies have shown that vasopressin based increase in sodium reuptake is dependent on the 
abundance of microtubules (Verrey et al, 1995) and Golgi apparatus in the cytosol (Kleyman et 
al, 1994). Overall, this allows the agonist to bring about a response in a fraction of the time 





Insulin, like vasopressin, is also thought to increase the ENaC population by inducing 
translocation of ENaC containing vesicles to the apical membrane (Blazer-Yost et al, 2003). 
Experiments were conducted on mouse taste receptor cells (TRC), specifically fungiform and 
vallate TRCs which exhibit functional ENaC currents. Here, insulin was shown to significantly 
increase the sodium current, which was then inhibited by amiloride, confirming the source of the 
current as ENaC. They also found that insulin-mediated increase in sodium current via ENaC 
was dependent on the enzyme phosphoinositide 3-kinase, which was inhibited using LY294002, 
abolishing the insulin induced current increase (Baquero et al, 2011). Within the kidney, 
regulation of ENaC by insulin was confirmed by Tiwari et al. (2011). Acute addition of insulin 
in mice showed a significant reduction in excreted sodium levels, indicating upregulated ENaC 
activity. Furthermore, this was corroborated by biochemical isolation of epithelial plasma 
membrane proteins from both insulin and vehicle treated (control) mouse kidneys, which 
displayed an increased ENaC population for insulin treated mice, confirming the hypothesis that 
insulin causes an increase in the ENaC translocation to the apical membrane (Tiwari et al, 2011) 
1.1.5.5- Proteolytic cleavage 
Increased ENaC activity via proteolytic cleavage was first investigated by Vallet et al. (1997), 
who found that upon introduction of a general protease inhibitor (aprotinin), there was an overall 
decrease in the amiloride sensitive current (Vallet et al, 1997). More specifically, it was found 
that proteases such as furin, which is a member of the pro-protein convertase family, found 
predominantly within the trans Golgi network, is important in the activation of ENaC via 
proteolytic cleavage (Hughey et al, 2004). Activation of ENaC via proteolytic cleavage is 




single site, all in the extracellular loops (ECL) (Hughey et al, 2003). Furin-dependent proteolysis 
of α-ENaC activates the channel by removing an inhibitory peptide from the ECL, resulting in 
activation of the channel by releasing self-inhibition, hence increasing sodium transport 
(Carattino et al, 2006). Consecutively, prostasin is thought to be present in the apical 
extracellular compartment, where it cleaves the γ subunit at a site in the ECL, again, releasing an 
inhibitory peptide which further activates the channel (Burns et al, 2007). Initial observations 
using a general protease inhibitor were found to cause a partial decrease in the amiloride 
sensitive current. These were done in Xenopus laevis A6 collecting duct cells and results 
suggested ENaC was regulated by an endogenous serine protease. This was confirmed by 
addition the protease; prostasin. When co-expressed with ENaC within oocytes, prostasin 
augmented the amiloride sensitive current, indicating an increase in ENaC activity (Nakhoul et 
al, 1998). Previous research by Masilamani et al, also supports this, who found biochemical 
evidence for cleavage, by demonstrating how addition of aldosterone resulted in a decrease of 
the γ subunit molecular weight (from 85kD to 70kD), suggesting cleavage of the γ subunit 
contributes to the increased current by increasing open probability (Masilamani et al, 1999). 
1.1.5.6- Phosphorylation 
ENaC has been identified to be regulated by a number of kinases, both directly and indirectly. 
Multiple kinases have been found to directly downregulate ENaC, these include ERK2 (Shi et al, 
2002) and casein kinase 2 (CK2), which phosphorylate the carboxy terminal of the β and γ 
subunits, promoting Nedd4-2 mediated internalization (Shi et al, 2002). Furthermore, 
downregulation also occurs via protein kinase C (PKC) mediated phosphorylation. Stimulated 
through extracellular purinergic receptor activation, PKC phosphorylation leads to a decrease in 




(Booth et al, 2003). Conversely, increased regulation can also be achieved through 
phosphorylation. CK1 and PKC-δ target the carboxy terminal of α-ENaC to increase the 
insertion of channels in the plasma membrane (Yan et al, 2007; Yan et al, 2006). The G-protein-
coupled-receptor kinase (GRK2) also works to prevent downregulation via disrupting the Nedd4-
2 and ENaC interaction. GRK2 directly phosphorylates the carboxy terminal of the β subunit, 
inhibiting Nedd4-2 binding, effectively decreasing ENaC ubiquitination and downregulation 
(Dinudom et al, 2004). 
1.1.5.7- Ubiquitin ligase pathway 
A reduction in channel conductance is brought about by reduction of channel number, which in 
relation to ENaC is regulated predominantly by the ubiquitin ligase pathway. ENaC has been 
identified to interact with the ubiquitin protein ligase neural precursor cell expressed 
developmentally down regulated protein-4 (Nedd4-2) (Staub et al, 1996), and becomes 
ubiquitinated on the α, β and γ subunits (Dinudom et al, 1998). The purpose of ubiquitination is 
to provide a labelling system, identifying proteins which need to be internalised, with the level of 
ubiquitination (mono/ poly-ubiquitination) determining if a protein is recycled or degraded 
(Hershko & Ciechanover, 1998). The process targets lysine residues on ENaC, attaching single 
or multiple ubiquitin molecules, initiating a cascade leading to the degradation of ENaC. 
Breakdown is carried out by lysosomes containing degradative enzymes that can be inhibited to 
alter the rapid rate of turnover (Staub et al, 1997), see Figure 1.3. On all 3 subunits of ENaC, the 
C terminal domain (found intracellularly) contains a proline rich motif (PPxY). This allows the 
WW domains of Nedd4-2 to attach and link ubiquitin molecules to the channel, hence any 




terminally preventing ubiquitination of the channel and giving rise to dysfunctions such as 
Liddle’s syndrome (Shimkets et al, 1994). 
 
1.1.6- ENaC Dysfunction 
Genetic mutations or alterations during composition (transcription/ translation) can lead to 
dysfunction in ENaC activity and regulation of membrane population, both of which hold 
importance in several human diseases (Bhalla & Hallows, 2008). These include multiple forms 
of hypertension, pseudohypoaldosteronism type I and also exacerbation of symptoms 
characteristic of other genetic dysfunctions (Cystic Fibrosis) (Donaldson et al, 2007). Ultimately, 
Figure 1.3. Downregulation of ENaC via the ubiquitination pathway. ENaC specific 
endocytosis and recycling pathway is represented as a schematic, including the ubiquitin ligase Nedd4-2 
which tags ENaC with ubiquitin. The protein is then internalized using clathrin coated vesicles through 
an interaction with epsin, and is sent to the early endosome (EEA1). From here it is either de-
ubiquitinated by DUB and recycled to the apical recycling endosome (ARE) or degraded in the lysosome. 




the change in the open probability of the channel, or in the population at the apical membrane 
characterize gain of function and loss of function mutations. 
 
Gain of function (GOF) often leads to a chronic increase in the sodium transported through 
ENaC. Within the nephron, specifically the distal convoluted tubules, this increase is often due to 
mutations which prevent internalization of ENaC, causing increased population and open 
probability of ENaC (reviewed by Soundararajan et al, 2012). The sodium transport is vectored 
from the nephron lumen (high sodium concentration) towards the peritubular capillaries (low 
sodium concentration) following the concentration gradient (in order to achieve electrochemical 
equilibrium). As the increase in sodium increases the tonicity of ECF, the osmotic gradient 
induces an increase in uptake of water into the peritubular capillaries, increasing reabsorption 
and retention of water, ultimately resulting in hypertension. Contrary to this, a loss of function 
follows the opposite method to GOF, they decrease activity/ function of ENaC, decreasing 
sodium flow, leading to decreased water retention (Lifton et al, 2001). 
1.1.6.1- Liddles syndrome 
A well characterised and corroborated link between ENaC dysregulation and hypertension is 
observed in Liddle’s syndrome (Liddle et al, 1996). Liddle’s syndrome is an autosomal dominant 
disease caused by a mutation within the α, β or γ subunits of ENaC (Shimkets et al, 1994; Salih 
et al, 2017). Classified as a GOF mutation, it alters the channels trafficking and increases cell 
surface expression. The mutation is predominantly present in the β subunit, where alterations 
within the genetic coding result in a premature stop codon, causing premature termination and 
truncation of the protein at the carboxyl (C terminus) end of the protein (Shimkets et al, 1994). 




mediated regulation. The lack of PPxY prevents ubiquitination by Nedd4-2, inhibiting the 
endocytosis of the channel, causing over activity, resulting in increased sodium reabsorption, 
eventually leading to early onset of salt-sensitive hypertension. Clinically, coupled with the 
increased sodium absorption, Liddle’s also results in hypokalaemia, metabolic acidosis, lowered 
aldosterone levels and volume expansion related hypertension (Lu et al, 2007). 
1.1.6.2- Pseudohypoaldosteronism type-1 
Prevalence for loss of function (LOF) mutations are lower in comparison to GOF. Following the 
opposite method to GOF, they decrease activity/ function of ENaC, decreasing sodium flow, 
leading to decreased water retention. A specific loss of function mutation involving ENaC is 
Pseudohypoaldosteronism type-1 (PHA1), an autosomal recessive disease caused by genetic 
changes including frameshifts, premature termination or missense mutations. This results in 
reduced ENaC activity, and subsequent decreased sodium reabsorption, resulting in volume 
depletion as the nephron is unable to retain water. Symptoms therefore include low blood 
pressure (hypotension), hyperkalaemia (Lifton et al, 2001), metabolic acidosis and 
unresponsiveness to mineralocorticoid hormones such as aldosterone (Chang et al, 1996). 
1.2 - S100A10/ p11 
1.2.1 – S100 family 
S100 is a large family of acidic proteins that contain 2 EF-hand calcium binding motifs, making 
them calcium dependent in their properties. The S100 family is composed of 20 different 
members, 16 of which originate from chromosome 21 (Fritz & Heizmann, 2004). This family of 
proteins have a relatively small molecular size (10-12 kDa) and are present in a large array of 




signal transmitters which respond to intracellular calcium rises by binding to cellular target 
proteins and modulating their activity (Rescher & Gerke, 2008). Different S100 proteins show a 
level of tissue specificity, furthermore, they often form homo- and heterodimers, which further 
contributes to their diversification (Marenholz et al, 2004). They contribute to many of the cells’ 
trafficking functions and are also involved in cellular processes such cell cycle progression and 
differentiation. Although they are primarily found intracellularly, they can also be found in the 
extracellular space, where their affinity towards other ions such as zinc and copper play a role in 
influencing their extracellular activity. The two EF-hand structures are present at each terminal; 
the N terminus contains an EF-hand specific to the S100 proteins which is then adjacent to a 
calcium binding EF-hand at the C terminal end (Marenholz et al, 2004).  
1.2.2- S100A10/ p11 Structure and Function 
The S100A10 or p11 protein, the focus of my study, is part of the S100 family in regards to its 
genetic sequence and physical structure of the signature EF-hand model, but p11 is unique in the 
sense that it has aquired both deletions and mutations in its EF-hand domains (Kwon et al, 2005). 
This alters the calcium binding sites, by causing a permanent protein conformation change which 
resembles the calcium loaded state of p11, making the normal Ca2+ regulated EF hand function 
redundant (Marenholz et al, 2004). As a result, p11 is calcium independent (Gerke & Webber, 
1985). As a functional consequence, this allows p11 to permanently be in an activated state, 
resulting in continuous activity without the necessary calcium influx (Rety et al, 1999). P11 has 
also been identified to aid in trafficking of multiple epithelial proteins. For this function, p11 is 
commonly understood to collaborate with Annexin2 (A2) to form the A2-p11 complex, where 




for this model comes from Domoto et al. (2007) who found that expression of p11 is 2.5-fold 
higher in cells with increased protein expression such as cancer cells (Domoto et al, 2007). 
1.2.2.1 – Annexin 2  
Annexin2 is a soluble, calcium binding protein from the Annexin2 multi-gene family (Borthwick 
et al, 2008) which is present in lipid bilayers. It was discovered that p11 modulates the properties 
of Annexin2 once they form the heterotetrametric complex A2-p11, including increased affinity 
for calcium and lipids, while inhibiting phosphorylation of Annexin2 (Powell & Glenny, 1987). 
As a monomer, the Annexin2 molecule is localized around the nucleus and cytosol, however, 
once it forms the A2-p11 complex, it is predominantly found in the cytoskeleton surrounding the 
cell surface membrane (Puiseux et al, 1996). Annexin2 is also found associated with plasma and 
early endosome membranes, and therefore, as part of the A2-p11 complex, it is believed that 
membrane binding is carried out specifically by the Annexin2 subunit (Rescher & Gerke, 2008). 
The affinity for plasma membrane is thought to originate from its ability to interact with 
negatively charged phospholipids in a calcium dependent manner (Gerke et al, 2005). For 
example, as part of a tetramer with p11, Annexin2 binds directly to the negatively charged 
phosphatidylinositol bisphosphate (PIP2) which is located in the cell membrane (Hayes et al, 
2004). 
1.2.2.2 – A2-p11 Complex 
For the A2-p11 complex, Annexin2 and p11 form a symmetrical heterotetrameric complex (Van 
De Graaf et al, 2003) within the cytoplasm. Annexin2 contains binding sites for p11 on the N 
terminal domain/ region which form amphiphatic α-helices from 12 amino acid residues 
(Johnsson et al, 1989). The complex belongs to the S100 calcium-binding protein superfamily 




trafficking (Marenholz et al, 2006). This is carried out through interactions with actin filaments 
to mediate membrane-membrane and membrane-cytoskeleton interaction, enabling the complex 
to regulate the translocation and function of epithelial channels (Okuse et al, 2002). Figure 1.4 
identifies the proposed mechanism of annexin-p11 function, where it is understood that the 
complex is co-dependent in trafficking, where p11 is required to interact with the protein, while 









1.2.3 – Proteins regulated by A2-p11 complex 
A few of the channels A2-p11 has been identified to interact with include the cystic fibrosis 
transmembrane conductance regulator (Borthwick et al, 2007), sodium-potassium-chloride 
channel (NKCC2) (Dathe et al, 2014), epithelial calcium channels (TRPV5 and TRPV6) (Van 
De Graaf et al, 2003), and the background potassium channel (TASK-1) (Girard et al, 2002). 
The relationship between the complex and these proteins is thoroughly established, where 
Figure 1.4. Hypothesised mechanism for p11 trafficking of ENaC. ENaC contained within a vesicle 
is transported by the A2-p11 complex to the cell surface membrane, providing a net positive effect in the 




inhibition of Annexin2-S100A10 complex formation reduces population of the channels at the 
cell surface.  
1.2.3.1- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) 
CFTR is a Cl- channel present within the pulmonary epithelia and plays a major role in 
maintaining the pulmonary surfactant. CFTR was found to bind with the Annexin-p11 complex 
and this interaction is needed for its exocytosis. Not only this, but it was also found that the 
generation of cAMP/PKA within the epithelial cells would in turn stimulate calcineurin A (CnA) 
formation, which acts as a catalyst for the A2-p11/CFTR complex formation. This was validated 
by the application of CnA inhibitors such as cyclosporine A, which disrupted complex formation 
and attenuated CFTR function, demonstrating that a lack of A2-p11 complex formation prevents 
CFTR trafficking in cystic fibrosis patients (Borthwick et al, 2007). 
1.2.3.2- Na-K-Cl Cotransporter 2 (NKCC2) 
For other epithelial channels such as the renal NKCC2 cotransporter, the A2-p11 complex has 
been found to be phosphorylation dependent rather than CnA dependent. Not only this, but as 
compared to binding directly to the protein such as CFTR, the A2-p11 complex interacts with 
lipid rafts which contain the NKCC2. This was further supported by experiments with 
phosphomimetic Annexin2, which carried a mutant phosphoacceptor which causes it to be 
constitutively active, resulting in an 5-fold increase of NKCC2 raft association and surface 
expression (Dathe et al, 2014). This suggests that proteins which interact with the A2-p11 
complex are not necessarily specific, creating an argument for why they may be involved with 




1.2.3.3- Leaky Potassium Channel TASK-1 
This trend of p11 trafficking channels is continued when looking at other channels such as the 
TRPV5/6 calcium channels (Van De Graaf et al, 2003) or the leaky potassium channels (TASK-
1) (Girard et al, 2002). Furthermore, the ability of p11 alone and the A2-p11 complex to traffic 
these apical proteins suggests it is highly likely to be involved with similar proteins such as 
ENaC. 
1.2.4 – Proteins Regulated by p11 Independently 
Although a majority of its function occurs in coexistence with Annexin2, p11 alone is also able 
to control the trafficking of epithelial channels. 
1.2.4.1- ASICs 
P11 regulates channels such as the acid sensing ion channels (ASICs). ASICs are voltage-
independent H+ gated ion channels which belong to the same family of proteins as ENaC 
(amiloride sensitive degenerin/ epithelial sodium channel superfamily). A study by Donier et al. 
(2005) using FLAG tagged ASIC1a and green fluorescent protein tagged p11 (p11-GFP), found 
an increase in the plasma membrane fluorescence corresponding to ASIC1a when cells were 
transfected with p11-GFP as compared to cells transfected with only GFP. Importantly, this 
experiment was performed without the additional transfection of Annexin2, which is required for 
the A2-p11 complex formation. Overall, results showed that p11 binds ASIC1a, at the 
intracellular N-terminal region and increases the population of ASIC1a at the cell surface, all 
without the required parallel increase in Annexin2 (Donier et al, 2005). The authors concluded 




1.2.5 - p11 and ENaC Interaction 
Previous research at the University of Otago had confirmed an interaction between ENaC and 
S100A10 using GST pull down assays. With the current lack in knowledge of ENaC exocytosis, 
this could potentially be a breakthrough in understanding how ENaC trafficking is regulated. Not 
only is the information around exocytosis insufficient, it is filled with uncertainty, and hence 
requires further exploration. Trafficking of ENaC is fundamental to its function, and due to the 
implications of changes in ENaC cell surface population in blood pressure regulation, 
understanding the channel trafficking and processing could lead to a deeper knowledge of the 
mechanisms behind hyper/ hypotension, potentially allowing for new therapeutic solutions. 
Therefore, we wanted to further build on the current knowledge by finding a functional 
consequence of the relationship between ENaC and p11. 
1.3- Aims and hypothesis 
As mentioned previously, ENaC plays a critical role in the regulation of Na+ and water in the 
body, determining the blood pressure. Therefore, regulation of ENaC activity is vital for 
maintaining homeostasis, with any dysregulation resulting in diseases such as Liddles and 
pseudohypoaldosteronism type-1. To develop our understanding of ENaC regulation, we wanted 
to look at p11, a protein with significant evidence to be involved with exocytic processes of 
epithelial channels, with promising potential that it will aid in our general understanding of 
ENaC exocytosis. Therefore, we proposed an experiment to observe the effects of p11 on the 
ENaC exocytosis/ translocation process.  
We hypothesized that p11 is involved in the exocytic targeting of ENaC to the apical plasma 




1- To identify whether overexpression of p11 increases amiloride sensitive current  







2.1- Xenopus laevis  
Oocytes from Xenopus laevis frogs were used to study the overexpression of p11 in regards to its 
function in ENaC trafficking. The oocytes were used to heterologously express ENaC and also 
co-express both ENaC subunits (within a pTNT vector) and the trafficking protein S100A10/p11 
(within the RC204992 vector), using their respective cDNA/ cRNA as displayed in Figure 2.1 A 
and B. The ENaC expression was tested using electrophysiological recording methods, 
specifically, the two-electrode voltage clamp (TEVC). Use of Xenopus laevis was approved by 
the Environmental Protection Authority (EPA approval number: NOC100153), and harvesting 
was approved by the University of Otago Animal’s Ethics committee. 
2.1.1- Xenopus housing and oocyte harvest 
The frogs were imported and housed within a Tecniplast Xenuplus housing system. Up to 4 frogs 
were housed per unit, and differentiated using their unique skin patterns. Water within the units 
was maintained at a constant temperature and pH, with sanitation maintained by filtering the 
water multiple times using a pre, biological, membrane and a carbon filter, with a final 
sterilization using a U.V. light for 20 minutes. 
Each frog was harvested for oocytes a maximum of 4 times, with each surgical procedure 
separated by 3 months. This part was carried out by Dr Daniel Barth on my behalf and I 
observed, as the procedure requires former experience. Firstly, the frogs were collected using a 
net and anesthetized in a water container using tricane methane sulfonate (MS-222, Aldrich, Cat. 
No. E10521-50G) (1.3g/l, buffered to a neutral pH) for approximately 10-15 minutes. To ensure 




reflex is triggered and they were non-responsive to the painful stimuli. The frog was placed in 
the dorsal recumbent position on sterile towels (soaked in MC-222). The upper and lower 
extremities (besides abdomen) were also covered with sterile towels, with surgical instruments 
sterilized/ autoclaved before the procedure to prevent bacterial infection. The frog abdomen was 
swabbed with a Povidinegauze sponge, and the lower left/ right of the abdomen folded parallel to 
the midline, for the first cut, which is made through the skin and a second through the muscle 
layer. Other fascia and tissue was moved until an ovarian lobe is visible, and then the lobe was 
extracted through the incisions and placed within a plate holding culture oocyte Ringer’s solution 
(culORI). Both the muscle and skin incisions were sutured independently and the frog was 
allowed to recover in a clean water tank. 
2.1.2- Oocyte isolation/ injections  
Once extracted, the ovarian lobes were torn in a petri dish containing buffer solution culORI 
thereby releasing the oocytes. Following this, the oocytes are defolliculated enzymatically using 
a collagenase (Serva, Cat. No. 17465.02) containing culORI solution (1.5mg/mL) and incubated 
for 90 minutes on a rocker (Select BioProducts, platform rocker Rock-it). Next, the oocytes are 
washed 3 times with Ringers and incubated in final wash for 15 minutes in calcium free oocyte 
Ringers solution. At this point a subset of the oocytes were given to me for my experiments. The 
healthiest and largest stage V-VI oocytes are selected and stored in a 96-well plate containing 
ND96 solution (all in mM; 96 NaCl, 1 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES buffering agent (1/2 
Na salt)), and are allowed to incubate for 24 hours. 
New injection tips are made using a laser based micropipette puller (Sutter instruments Co. 
Model P-2000) with 15 cm capillary tubes. The fabricated injectors are filled with mineral oil to 




barrel is emptied using the foot pedal till approximately 3 – 4 cm of the barrel is visible and the 
injection tip is attached to the injector (World Precision Instruments, Micro4 MicroSyringe 
Pump Controller). Using the Leica overhead microscope, the injection tip is cut of excess glass 
and oil pushed out to remove air bubbles. The RNA is withdrawn at a rate of 150nl/click, making 
sure no air bubbles are withdrawn. The oocytes are then placed in an oocyte holder unit within a 
5 x 5 cm petri dish containing low sodium ND96. Here the oocytes are injected with 15 nL of 
cRNA and returned to a 96-well plate filled with low sodium ND96 to prevent sodium loading 
through the ENaC. The oocytes are incubated at 170C in an incubator (Lab Companion, Personal 
Incubator, ILP-02) for 24 hours to allow for protein expression before recording with two 















Figure 2.1. Schematic showing the process of heterologous expression within Xenopus 
oocytes. (A) showing the insertion of human cRNA (from cDNA) into an oocyte. The cRNA undergoes 
translation into individual subunits, from where they are expressed at the cell surface. (B) represents an 




2.2- FRT cells 
2.2.1- Cell maintenance and passaging 
Fisher rat thyroid (FRT) cells were used due to their ability to form an epithelia and express 
p11endogenously, and these cells had previously been used successfully in the McDonald lab for 
knockdown experiments. Cells were passaged once 80-90% confluence was achieved (every 3-4 
days), to prevent overgrowth of the culture. To avoid any external contamination, all passaging 
and cell seeding was carried out in a physical containment 2 laboratory, using a sterilized laminar 
flow hood (Labconco Purifier Biological Safety Cabinet). 
FRT cells were grown in full Ham’s F12 nutrient mixture (Coon’s modification, Sigma Aldrich, 
Missouri, USA, Cat No. F6636) medium which was supplemented with 10% fetal bovine serum 
(FBS, Invitrogen) and 1% penicillin/streptomycin antibiotic (10,000µg/mL penicillin & 10,000 
µg/mL streptomycin, Gibco, Thermo Fisher Scientific, US, Cat No. 15140122) to prevent 
bacterial infections, in 100 x 10 mm stock plates (Corning Centristar, NY, USA, Cat No. 
430166). Each culture plate was maintained in a humidified cell culture incubator (Forma series 
II, Water Jacketed 𝐶𝑂2 Incubator. Thermal Electrol Co.) at 37
0𝐶 with 5% 𝐶𝑂2 with regular 
checks for adequate growth or infection 
To prevent overgrowth, the culture was passaged once a confluence of 80-90% was attained. 
Working solutions were pre-warmed in a water bath at  370𝐶 for 15-20 minutes. When ready, 
the spent culture medium was aspirated and followed by a single wash with 1-2 mL of 
phosphate-buffered saline (PBS, Sigma-Aldrich, Missouri, USA, Cat No. P4417). After using 
slight movement of the plate to assure wash, the PBS was removed and cells were incubated in 2 




optimal at 370𝐶, cells were left to incubate at 370𝐶  with 5% CO2 for 10-15 minutes to ensure 
dislodgement. Post incubation, the trypsin is deactivated by addition of 4 mL of F12 growth 
media. The culture was then centrifuged at 13200rpm for 10 minutes to pellet the cells. Then 
cells were resuspended in 3 mL growth media and used for one or more of the following: 1) cell 
counting (see below), 2) subsequent seeding on Snapwell filters (for Ussing experiments), 3) on 
60 x 35 mm plates (for western blotting) and 4) preparing a new stock culture plate with a 1:4 
ratio (1 mL of cell suspension in 4 mL of F12 growth media). 
2.2.2- Cell counting  
For cell counting, 10 µl of the cell suspension was placed on a sterilized haemacytometer and 
observed using the inverted CKX41 Olympus microscope (Olympus, Cambridge, UK). The 
centre grid is used to count cells within a certain limit, with the resultant number ( χ ) indicating 
the cell concentration. This number was substituted into the following equation in order to 
identify the volume required for seeding at a density of 4.5x105 cells. Once seeded, the cells 
were allowed to incubate a minimum of 24 hours before transfection. 
𝑉𝑜𝑙𝑢𝑚𝑒 𝑓𝑜𝑟 𝑠𝑒𝑒𝑑𝑖𝑛𝑔 =
number of cells wanted (4.5x105 )
density of counted cells (𝑥)
 
 
2.2.3- Cell transfection 
24 hours after seeding, FRT cells were transfected using the Lipofectamine 3000 (Invitrogen, 
USA, Lot No. 1699504), which allows the transport of DNA into the cell for transcription and 
subsequent protein expression at the ER. Prior to starting the transfection, the full F12 media is 





removed from the cell cultures and replaced with serum free (SF) F12 to prevent liposome 
breakdown. While the culture incubates in SF F12, the transfection reagents are prepared in 2 
individual 1.5 mL tubes (A & B) per Snap-well/ culture plate. Tube A is prepared with 50 µL SF 
F12 and 3 µL of Lipofectamine 3000, and left to incubate at room temperature for 5 minutes. 
Tube B is prepared with; 50 µL SF F12, 2 µL P3000, 1 µL ENaC plasmids (0.2 µg (0.067 µg per 
subunit)) and 1 µL control siRNA (20 pmol) or 1 µL p11 siRNA (20 pmol). The contents of the 
two tubes were then combined and applied to the Snap-well filters and/or culture plates as seen 
in Figure 2.2. Finally, the cells were allowed to incubate in the transfection mixture for 6 hours, 
after which, the SF F12 media was aspirated and replaced with full F12 for the Snap-wells (3 mL 
basal, 350 µL apical) / culture plate (3 mL) and placed back into the incubator for 72 hours to 









2.3.1- Two Electrode Voltage Clamp (TEVC) 
Glass capillary tubes (Hilgenberg, Cat No. 1103237) are used to produce outer coverings of the 
electrodes, by using a flaming/brown micropipette puller (P-87, Sutter instruments Co. Novato, 
USA) that creates narrow tipped electrode covers. The microelectrodes were chloride silver 
wires which were inserted into the glass capillaries which were pre-filled with 1M KCl (≈ 20 
µL). The capillaries were checked and removed of any air bubbles. The electrodes are then 
connected to the TURBO TEC-05 TEVC amplifier (npi, Tamn, Germany) which was used to 
clamp the oocytes to a membrane potential of -60mV, as seen in Figure 2.3, allowing any 
transmembrane voltage and differences in voltage to be recorded via a PowerLab 4/35 
Figure 2.2. Snapwell used for cell seeding and transfection for Ussing chamber 
recordings. The FRT cells were applied apically to the Snap-well filter (centre) with media for a total 
volume of 400 µL and 3 mL of media in the basal side. The filter separates the apical and basal side, 
allowing the FRT culture to form a polarized monolayer. The filter is removed and placed into the 




(ADInstruments, Dunedin, New Zealand). The oocytes are gently transferred into the perfusion 
bath and carefully impaled with both the current and potential electrodes. At this point the 
amplifier is calibrated to the desired settings which will allow for precise recordings of the target 
ion channel. Once ready, the bath is perfused with ND96 solution from the perfusion system 
(Scientific Instruments, PR-10 Pressure Regulator), additional pressure was applied to increase 
flow rate. The perfusion system contains many solution containers, of which, container A was 
filled using normal ND96 solution, while container B is filled with ND96 + amiloride (50 mL 
ND96, 100 µL of 5mM amiloride). The flow of these is controlled via switch from the VC-6 
Channel Valve Controller (VC-6, Warner Instrument Co.).  
For the recordings, ND96 was perfused to achieve a baseline current using PowerLab. Once 
current was settled at a reached equilibrium, ND96 + amiloride was perfused into the chamber, 
stimulating a shift in current by blocking ENaC and preventing Na+ flow, identifying the trans-
membrane amiloride sensitive current (Isc - amiloride). Finally, the perfusion was changed back 
to ND96, returning the oocyte membrane current to baseline to confirm the baseline value. Once 
recorded, the oocyte is disposed of in a biological waste bin (except when collected and stored 
for protein isolation), and the next oocyte is loaded into the perfusion bath. Due to oocyte 







2.3.2- Ussing Chamber Recordings 
Electrodes for the Ussing chamber were made from plastic tips filled with 3% molten agar in 3M 
KCl (3g agar/100 mL of 3M KCl) approximately 5 mm past entry point of tip. 3M KCl is then 
backfilled to the top of the tip, and the voltage and current electrodes are then inserted into these 
tips with care to prevent air bubbles. 
Before the experiments are recorded, the Ringer’s solution (all in mM; 135 NaCl, 1.2 MgCl2, 4.2 
K2HPO4, 0.6 KH2PO4, 10 HEPES, 1.2 CaCl2 – pH 7.4) is placed within a water bath (41°C). The 
computer, clamp and oxygen are started 10 minutes prior to recordings to allow for warm up. For 
the system calibration, the Ussing chamber apparatus is assembled with a dummy filter (a 
Snapwell with filter removed), and the apparatus is inserted into the holder and tightened to 
prevent any leakage of the solutions. The electrodes are inserted, making sure the apical side is 
inserted on the left side of the chamber, with the electrode openings facing the midline of the 
Figure 2.3. Schematic representation of the TEVC apparatus. The current and potential electrodes are 
placed within the oocyte and the oocyte clamped at -60 mV. The negative charge within the cell provides an 
electrochemical gradient for positively charged Na+ to flow into the oocyte. Hence, blocking of ENaC with 




apparatus. As seen in Figure 2.4, the chamber is filled with 5 mL of Ringer’s solution in each 
side using syringes to prevent air bubbles. The voltage clamp was set up using the amplifier, to 
ensure voltage and resistance differences are neutralized to a 0 reading. The system is referenced 
using Acquire and Analyse (Physiologic Instruments, USA), after which a Snapwell containing 
FRT culture was placed into the Ussing chamber and recorded for trans-epithelial current and 
resistance. To ensure the epithelia was healthy, only recordings with resistance above 300Ω/ cm2 
were used in final results. 
Initially, the recording was set to a high frequency, after which they are returned to a slower rate. 
The cells were allowed to stabilize until the current reached equilibrium which took anywhere 
from 10-30 minutes, before 10 µL of 5 mM amiloride was added to the apical portion of the 
chamber. Once the amiloride sensitive shift was observed, the current was allowed to return to 
baseline, before the experiment was terminated. Once the experiment was finished, the total data 





2.4- Protein analysis 
2.4.1- Western blot 
In order to identify the presence of p11 within the cell samples, the western blot method was 
used. Western blotting allows for the detection of a protein expressed within the target cell, and 
to compare the level of protein expression between two samples with different conditions, for 
example, comparing endogenous p11 amount to that of a p11 knockdown sample. The technique 
is a multi-stage process, including; cell lysis, gel electrophoresis, protein transfer to a solid 
support membrane, protein visualization and analysis (Towbin et al, 1979). 
Cell lysis is required to break open the cellular structure and extract the proteins for analysis. In 
order to lyse the cells, detergents were used to dissociate the lipids which composed the cell 
membrane, releasing the cellular and membrane bound proteins into a lysate mixture.  
 
Figure 2.4. Ussing chamber apparatus. The chamber is separated into apical and basal portions to 
allow for recordings of ion flow. The chambers were filled with Ringers solution pre-warmed to 370C. 
the Snapwell filter is placed in the centre with the apical portion facing left, hence to record Isc-




2.4.2- Sample preparation- oocytes 
To compare the level of p11 protein between control (ENaC alone) and overexpression group 
(ENaC+p11), the oocytes were injected with 15nL of either heterologous ENaC cRNA (control) 
or ENaC + p11 cRNA, using the micro-injector. Post TEVC recording procedure, 5 oocytes from 
both control and intervention groups, which provided adequate current traces, were salvaged and 
kept in a centrifuge tube for protein analysis. 40 µL of RIPA buffer (20 mMTris-HCl (pH 7.5) 
150 mM NaCl, 1 mM Na2EDTA 1 mM EGTA 1% NP-40 1%sodium deoxycholate 2.5 
mM sodium pyrophosphate 1 mM β-glycerophosphate 1 mM Na3VO4 1 µg/ mL leupeptin) was 
added to each centrifuge tube and the mixture was sonicated for 20 seconds using a (Wave 
Energy Systems, Ultra Tip, Newtown, PA), after which, the mixture was left on a rotator 
overnight at 40C. The samples were then centrifuged at 13200 rpm (Eppendorf, Centrifuge 5415 
R, Cat No 132521) at 40C for 10 min to separate the supernatant from the protein pellet. The 
supernatant was relocated to a fresh 1.5 mL tube, which was used as the oocyte protein sample, 
and the pellet discarded. The sample was stored at -800C until used. 
2.4.3- Sample preparation- FRT cells 
After passaging of FRT cells, two separate 5 x 5 cm plates were seeded with 4.5 x 105 cells for 
protein analysis, specifically to identify the presence of p11. 24 hours post seeding; the cells 
were transfected with either 20pmol of control siRNA or p11-siRNA following the same method 
for transfection as described previously. The seeded and transfected plates were grown in full 
F12 media over 3 days within an incubator at 370C and 5% CO2. It is important to note, during 
the process of preparing the cells for the protein analysis, they were kept on ice to prevent 
protein degradation. Once the cells had reached a confluency of 80-90%, the used F12 media 




TBS, 10 mM Tris, 50 mM NaCl, pH 8, containing 1% Triton X-100, 10µg/mL PMSF, 2µg/mL 
leupeptin, 2µg/mL aprotinin and 1µg/mL pepstatin protease inhibitors) was added to each culture 
plate and placed on a rocking platform (on ice) to release the cellular proteins for 10 mins. Once 
the cells had lysed, they were collected into an aggregate using a cell scraper and transferred to a 
1.5 mL tube. The cells were then centrifuged at 13,200 rpm and 40C for 10 minutes (Eppendorf, 
Centrifuge 5415 R, Cat No 132521), with the resultant supernatant salvaged into another 1.5 mL 
tube as the protein sample, and the pellet discarded.  
To prepare the sample used for running in the SDS-PAGE (sodium dodecyl sulfate (SDS) 
polyacrylamide) gel, the supernatants from both the oocytes and FRT cells were prepared 
identically from this point onwards for western blots. 30 µL of the protein sample was then 
loaded into another tube with 6 µL of 5x sample buffer (for a 5x stock: 1 mL 1.5M Tris (pH6.8), 
5 mL 10% SDS, 2.6 mL 100% glycerol, 0.8 mL 1% bromophenol blue, 0.6 mL ddH2O – prior to 
use 10% β-mercaptoethanol was added). This creates the running sample which was heated at 
950C for 5 minutes to denature the proteins before being loaded onto the SDS-PAGE gel. Note 
that at the time I was running the western blots the department’s Microplate reader for measuring 
protein concentrations was broken, therefore I could not read protein concentrations of my 
samples. Guided by the experience of others using similar samples the 30 µL volume was chosen 
as appropriate for my experiments. 
2.4.4- SDS-PAGE 
The SDS-PAGE gel electrophoresis technique is used to separate proteins depending on their 
molecular weight. The loaded protein samples are allowed to run on a polyacrylamide gel 




negatively charged proteins to travel towards the positive electrode, with the smallest proteins 
travelling furthest down the gel. 
12% polyacrylamide gels (10 mL) were prepared using the mixture outlined in Table 2.1. The 
gel was prepared using the Mini Gel caster (Hoefer, Germany).  The running (12%) and stacking 
gel (5%) were prepared separately, where the running gel mixture was poured into the mould 
first and allowed to set for approximately 60 min. 1mL of water saturated butanol was used to 
cover the top of the gel to prevent drying and evaporation while setting. Once set, the butanol 
was removed and 5 mL of stacking gel was poured into the mould, and allowed to set with a 
comb inserted in the mould to form the stacking wells. Once fully set, the gel was placed into a 
EC120 Electrophorator (ThermoEC, Holbrook, New York) and submerged in 1 x SDS running 
buffer (25 mM Tris, 190 mM glycine, 0.1% SDS, H2O). 7.5 µL of the pre-stained protein 
molecular weight marker (Kaleidoscope Prestained Standards, Bio-rad, California, USA, Cat 
NO. 161-0324) was loaded into the first well to provide accurate markings of specific molecular 
weights which allow for comparison to sample protein molecular weights. 36 µL of the protein 
samples were then loaded into consecutive wells using a pipette, and the gel was run at 150mV 
for 60 - 190 minutes using a Bio-Rad power pack. While the gel was running, 100 µL of western 
blot transfer buffer was prepared by adding 20 mL l MeOH + 60 mL l mQH2O to 20 mL of 5x 
transfer buffer (20% MeOH, 25mM Tris, 129mM glycine) and left at 40C until used. 12 pieces of 







2.4.5- Semi-dry protein transfer 
Once the gel has finished running, the proteins are now arranged from top to bottom in order of 
molecular weight. To analyse the protein size and concentration, they are transferred from the 
polyacrylamide gel onto a PVDF western blotting membrane (Roche, Basel, Switzerland, Ref 
No, 0310040001), in a process called electroblotting. The transfer from gel to membrane is 
performed using the semi-dry method. The process involves sandwiching the gel and membrane 
between 6 filter papers on either side, closed off by the negative and positive electrodes. The 
proteins are transferred from the gel to the membrane by passing a current through the several 
layers, inducing the transfer of proteins from gel to PVDF membrane. 
Once the gel had finished the run, it was removed from the Electrophorator and the stacking gel 
discarded, with an additional cut for orientation purposes. The transfer apparatus was prepared 
Table 2.1. Volumes of solutions used for preparation of both running and stacking gels. 10 mL of 
running gel was prepared and poured into the gel mould with butanol to prevent evaporation and allowed to set 
for 60 min. Once set, 5 mL of running gel was prepared and added to the mold with a comb to form the stacking 




by rinsing the anode with distilled water, and applying a mylar mask to cover the extra surface of 
the electrode to prevent current short-circuiting. The mylar mask contains an exposed section for 
the stack. Starting from the bottom, 6 pieces of filter paper were soaked in the transfer buffer and 
stacked on top of each other within the exposed section of the mask. The PVDF membrane was 
soaked in methanol for activation, followed by a wash in transfer buffer and placed on top of the 
filter paper.  On top of this, the polyacrylamide gel was carefully placed, and covered with the 
remaining 6 filter paper pieces, each soaked in transfer buffer and rolled with an empty glass 
test-tube to remove air bubbles. Finally, the cathode was rinsed with distilled water and placed 
on top of the stack, with a 500g mass to keep it in place. The cathode was attached to the anode 
via safely interlock and the transfer unit connected to the power supply. The transfer was run for 
2 hours at a constant voltage of 50 V and 45 mA (per 7 x 8 cm2 blot). 
 
2.4.6- Membrane blocking and immune staining 
To prevent any non-specific binding of anti-bodies to the PVDF membrane, the unbound sites on 
the PVDF membrane are blocked using 5% blocking buffer (2.5 g non-fat dry milk powder 
dissolved in 50 mL of TBS + 0.1% Tween-20). The proteins within the milk bind to the empty 




blocked overnight on a rotator (Ratek, Platform Mixer) to ensure complete coverage, in a 
refrigerator at 40C. Post blocking, the membrane was washed 3 times for 5 minutes with TBS-T 
(20 mM Tris, 150 mM NaCl, 0.1% Tween-20 (Sigma Life Science, USA, Lot No. 
MKBQ9465V), pH 7.5) to remove any excess blocking proteins. The membrane was then 
incubated in anti-p11 (Table 2.2) and incubated again at 40C overnight on a rocking platform. 
Following this, washes were repeated with TBS-T before the membrane was exposed to a 
secondary antibody (goat anti-mouse conjugated with horse-radish peroxidase (HRP), see Table 
2.2) and incubated for approximately 60 minutes at room temperature. Finally, the membrane 
was washed a last time with TBS-T before chemiluminescent detection of protein. 
 
2.4.7- Membrane development 
The PVDF membrane labelled with antibodies was taken to the dark room in order to detect the 
target proteins using enhanced chemiluminescent detection with Amersham ECL Prime Western 
blotting chemiluminescence reagents (distributed through Global Science, NZ; Cat No. 
GEHERPN2232). 1 mL of each ECL Prime Lumi-light reagent was mixed and applied to the 




PVDF membrane and incubated for 5 minutes at room temperature. The membrane was then 
placed inside the developing cassette between clear mylar sheets. X-ray film (Kodak, Cat N. 
1651454) was used to detect the ECL signals, and was applied superficial to the membrane. 
Once applied, the cassette was closed immediately and exposure time was varied depending on 
the strength of the signal. To avoid excess background signal, the exposure time was decreased, 
however, in cases of faint signals, the exposure time was extended to overnight. Post exposure, 
the film was washed through developer (Kodak, Cat No. 4037180), water and fixer (Kodak, Cat. 
No. 4037214), in that order, for approximately 2 minutes each. Finally, the film was rinsed with 
water and let dry. Once dry, the film was scanned using a photocopier (Epson Perfection, V370 
Photo), for analysis on a computer. 
2.5- Data Analysis 
The data from both the TEVC and Ussing chamber recordings was transferred onto Microsoft 
Excel for sorting. GraphPad Prism 7 was used for statistical analysis of the results (Student’s t-





The aim of this project was to determine whether the exocytic protein S100A10/p11 plays a role 
in the apical trafficking and function of ENaC. The effect of both an increase and a decrease in 
p11 was tested in relation to p11’s effect on ENaC trafficking. Previous research in the 
McDonald laboratory has shown that there is an interaction between ENaC and p11: using a GST 
pull down assay, all ENaC subunits were identified to interact with p11. Proof of an interaction 
led to the question of whether there was a functional consequence to this. The experimental 
procedure was divided into 2 parts; the first part focused on the effect of p11 overexpression on 
ENaC current in Xenopus laevis oocytes.  Secondly, siRNA to p11 was used to investigate the 
effect of decreasing p11 protein level on ENaC current in FRT epithelia. 
3.1- p11 overexpression 
3.1.1- TEVC confirmed functional ENaC expression in oocytes 
Initially, ENaC was expressed in Xenopus laevis oocytes (injected with ENaC cRNA) and the 
amiloride sensitive current was compared to a control group of water injected oocytes.  This was 
carried out both with and without additional p11 expression, and analyzing the subsequent 
effects on ENaC current using a two-electrode voltage clamp (TEVC). Two electrode voltage 
clamp allows the oocyte to be clamped at a certain voltage and to record any changes in oocyte 
membrane potential from ion flow. To identify the current generated by ENaC specifically, 
amiloride was administered once a baseline current was achieved. Amiloride is specific to ENaC 
and hence any shift in current upon amiloride administration indicates the inhibition of ENaC, 




α, β and γ-ENaC cRNA translated from pTNT plasmid vectors were injected into Xenopus 
oocytes using a microinjector (15nL) (0.75ng of each subunit). These were compared to oocytes 
injected with 15nl of water as a negative control. Oocytes were incubated for 24-hours to allow 
for protein expression, in low sodium buffer to prevent sodium loading through newly formed 
channels, and subsequent swelling due to osmosis. Post incubation, the oocytes were loaded into 
the TEVC apparatus for recording. Once impaled with current and potential electrodes, the 
oocytes were clamped at -60mV and perfused with ND96 solution to allow the transmembrane 
current to reach baseline over 2-5 minutes. As the oocytes reached equilibrium, they were 
perfused with ND96 + amiloride (10µM), blocking all functional ENaC channels, decreasing the 
transmembrane current and identifying an amiloride sensitive current (Isc-amiloride). 
Recordings of ENaC expressing oocytes displayed a much larger baseline current (-3.56 
±0.32µA) when compared to water injected oocytes (<0.1 µA). The ND96 solution contains Na+ 
ions which flow through ENaC to generate a baseline current, due to the negatively clamped 
oocyte (-60 mV). Upon amiloride administration, ENaC is blocked, reducing the inward flow of 
sodium, reducing the current. Therefore, we observed an average reduction in current of -3.349 ± 
0.3 µA upon amiloride application for ENaC injected oocytes, and no difference for water 










The lack of current change, and hence Isc-amiloride, in the water injected oocytes indicates no 
ENaC expression. This confirms the expression of functional ENaC within the oocyte cell 
surface membrane for oocytes injected with ENaC cRNA.  
3.1.2- Effects of p11 overexpression on ENaC 
After establishing that an amiloride-sensitive current could be generated, a series of batches of 
oocytes injected with ENaC were compared to oocytes co-expressing both ENaC and p11. In the 
first set of experiments to study the effects of p11 as a trafficking protein on ENaC expression, a 
1:1 ratio of ENaC: p11 was used i.e. the α, β and γ subunits of ENaC (0.75ng) were co-expressed 
with the p11 (0.75ng) protein in Xenopus oocytes, and the transmembrane current recorded using 
Figure 3.1. An amiloride sensitive current identifies the presence of the epithelial sodium channel 
within the Xenopus laevis oocyte. Representative traces from oocytes injected with heterologous α, β and γ-
ENaC cRNA (A) or water (B) to identify an amiloride sensitive current using a two-electrode voltage clamp. 
Oocytes were impaled with the current and potential electrode and clamped to -60 mV, allowing fluctuations in 
trans-membrane current to be identified. Upon amiloride administration (10 µM final concentration), ENaC 
channels are blocked, providing a characteristic drop in current. The difference in current pre and post amiloride 
administration identifies the Isc-amiloride. Amiloride sensitive current (Isc-amiloride) is identified by a bracket. 






the TEVC. After completing the recording, the Isc-amiloride was identified in the current trace 
(current change pre and post amiloride application), the data of the two groups from one batch of 
oocytes was compared after normalising with respect to control, to identify whether the presence 
of p11 increased Isc-amiloride as hypothesized. This would suggest the presence of p11 
increases ENaC trafficking and consequently, the amiloride sensitive current. 
Representative current traces for ENaC expressing (Figure 3.2. A) and ENaC + p11 expressing 
(Figure 3.2. B) oocytes can be seen in Figure 3.2. The presence of an amiloride sensitive current 
can be identified in both ENaC and ENaC + p11 oocytes for the TEVC, confirming the presence 
of functional ENaC. As expected, the TEVC traces show a trend for increased amiloride 
sensitive current in the p11 overexpression group, with the average Isc-amiloride for oocytes co-





The results in Figure 3.2 indicate that p11 may have an overall current increasing effect, 
suggesting an increase in translocation of ENaC to the cell surface membrane. This was repeated 
for a total of 8 weeks, to further identify a trend and reduce variability. 
Experiments conducted over weeks 1 - 4 looked at amiloride sensitive current for ENaC alone 
(0.75ng) vs ENaC + p11 (0.75ng each). Figure 3.3 shows that oocytes from week 1 (ENaC n=4, 
ENaC+p11 n=5), week 3 (ENaC n=5, ENaC+p11 n=6) and week 4 (ENaC n=4, ENaC+p11 n=3) 
displayed an overall increase in the amiloride sensitive current for ENaC + p11 compared to 
ENaC alone, with a decrease in week 2 (ENaC n=4, ENaC+p11 n=3) (Figure 3.3. A). When 
Figure 3.2. p11 causes an increase in the amiloride sensitive current when co-expressed with 
ENaC. Representative traces from oocytes injected with heterologous ENaC only (A) or both ENaC + 
p11 (B) using a micro-pipette injector. Using TEVC, oocytes were impaled with the current and potential 
electrode and clamped to -60 mV, allowing fluctuations in trans-membrane current to be identified. The 
oocytes were allowed to stabilize in the ND96 solution, and once the current reached baseline, ND96 + 
amiloride (10 µM) was administered to identify the Isc-amiloride. A visible difference is apparent 
between the two traces, where the Isc-amiloride is increased when ENaC is co-expressed with p11 as 







comparing all 4 weeks (Figure 3.3. B), although the average amiloride sensitive current for 
oocytes was increased in the presence of p11 (ENaC+p11) by an average of 12%, there was no 
significant difference (p=0.46) between ENaC alone (n=17) and ENaC + p11 (n=17) (N=4, 





On average, p11 co-expression caused an insignificant increase in normalized amiloride-
sensitive current at -60 mV from 1.0 (n = 16) in oocytes injected with ENaC cRNA alone to 1.1 
(n = 16) in oocytes injected with both ENaC and p11 RNA for weeks 1-4 (p=0.4). 
Although these results were not expected, they identified a trend in Isc-amiloride which 
supported the hypothesis; suggested that p11 was contributing to the increased ENaC current, 
Figure 3.3. Difference in 
amiloride sensitive current for 
oocytes expressing ENaC or 
ENaC + p11. Oocytes were 
harvested weekly for 4 weeks and 
injected with heterologous ENaC 
cRNA (0.75ng) (n=17) or both 
ENaC + p11 cRNA (0.75ng each) 
(n=17) to identify the effects of 
p11 on ENaC expression. A The 
amiloride sensitive current for 
weeks 1-4, normalized with 
respect to the control group 
(ENaC only). Co-expression of 
ENaC + p11 (red) showed an 
increase in the Isc-amiloride for 
weeks 1, 3 and 4 when compared 
to ENaC alone (blue). B Although 
an overall increase in current 
(12%) was observed, statistical 
analysis (Students t-test, 
unpaired) of ENaC injected against 
ENaC + p11 injected oocytes 
identified no significant difference 







potentially via increased trafficking. However, it is also possible that p11 is facilitating current 
changes via other mechanisms, with a positive effect too small to be significant. 
Following this, we replicated the overexpression experiment over another 4 weeks (weeks 5-8). 
However, due a lack of significance in week 1-4 results, the experimental procedure was altered 
to try and compensate for the variability. The insignificance was suspected to be a result of 
insufficient p11 cRNA, leading to inadequate expression. Therefore, the p11 concentration was 
doubled from 0.75ng to 1.50ng, while keeping the ENaC constant at 0.75ng.  
As shown in Figure 3.4. A, the results indicated a similar pattern to weeks 1-4, with week 5 
(ENaC n=4, ENaC+p11 n=4), week 7 (ENaC n=6, ENaC+p11 n=7) and week 8 (ENaC n=5, 
ENaC+p11 n=5) showing an increase in the amiloride sensitive current for the ENaC + p11 
group compared to ENaC alone, and again, a decrease in week 6 (ENaC n=7. ENaC+p11 n=7). 
Although an overall average increase in amiloride sensitive current of 17% was observed, the 
analysis (unpaired t-test) (Figure 3.4. B) showed an insignificant difference (p=0.24) between the 




On average, p11 co-expression caused an insignificant increase in normalized amiloride-
sensitive current at -60 mV from 1.0 (n = 17) in oocytes injected with ENaC cRNA alone to 1.2 
(n = 18) in oocytes injected with both ENaC and p11 RNA for weeks 5-8 (p=0.2). Although 
these results showed no significant difference between ENaC and ENaC + p11, previous TEVC 
experiments undertaken by my supervisor, Dr Condliffe, with identical conditions have shown a 
significant increase in amiloride sensitive current for ENaC + p11 co-expression compared to 
ENaC alone.  
Figure 3.4. Difference in amiloride 
sensitive current for oocytes 
expressing ENaC or ENaC + p11. 
Oocytes were harvested for another 4 
weeks and injected with heterologous 
ENaC cRNA (0.75ng) (n=22) or both 
ENaC + p11 cRNA (0.75ng ENaC, 1.50ng 
p11) (n=21) to identify the effects of 
p11 on ENaC expression. A The 
amiloride sensitive current for weeks 5-
8, normalized with respect to the 
control group (ENaC only). Co-
expression of ENaC + p11 (red) showed 
an increase in the Isc-amiloride for 
weeks 5, 7 and 8 when compared to 
ENaC alone (blue). B Although an 
overall increase in current (17%) was 
observed, statistical analysis (Students 
t-test, unpaired) of ENaC injected 
against ENaC + p11 injected oocytes 
identified no significant difference 
(p=0.24) between the two groups. A 
second analysis was carried out with 
week 6 removed due to non-optimal 
conditions of oocytes (small and weak). 
Students t-Test (unpaired) identified a 
significant difference between ENaC 
alone and ENaC + p11 (p=0.023) for  the 







3.1.3- Presence of Endogenous p11 in Xenopus Oocytes. 
Although my results did not provide a significant difference between the control and 
overexpression group, but other preliminary data from the Condliffe laboratory was sufficient in 
providing evidence for p11 presence to increase ENaC trafficking. Therefore, we wanted to 
identify whether the effects are confounded due to changes in endogenous p11 expression in 
oocytes. Oocytes which produced useable traces in the TEVC were salvaged and stored. 5 
oocytes were collected for each group, lysed using a lysis buffer and rotated overnight at 40C. 
The samples from each weeks 7 and 8 were combined with sample buffer, denatured and 
analysed on an SDS-PAGE to separate p11 from the other cellular proteins. The proteins were 
transferred to PVDF membrane, blocked using 5% milk powder in TBS-T buffer and incubated 
with a primary anti-p11 antibody (rabbit source) and a secondary anti-rabbit-HRP antibody (anti 
rabbit). Protein densities were visualized on photographic film using chemiluminescence.  
In Figure 3.5 the Western blot for p11 in oocytes is shown. The p11 protein recognized by the 
antibody (rabbit anti-p11) has an expected molecular weight of 11 kDa. However, Figure 3.5A 
did not show an obvious band at 11 kDa. Instead a smear of binding is apparent for the week 7 
samples in both ENaC alone and ENaC + p11 lanes, both in equal amounts. However, no protein 
bands were observed for the week 8 samples. The smears in the week 7 samples may be due to 
degradation of the protein samples or more likely nonspecific binding of the antibody, and this 
experiment was classed as inconclusive. In a second attempt with the same protein lysates, but 
different antibodies (mouse anti-p11) Figure 3.5B shows that a band at approximately 15 kDa 
was present in both ENaC alone and ENaC + p11 lanes in equal amounts. Again, there were no 
bands in the week 8 sample suggesting low or no proteins present in these samples. This band 




p11 sample (lane 2) compared to lane 1. Due to time constraints and using up all the protein 
samples the western blots were not repeated. 
  
Figure 3.5. Oocyte western blots from weeks 7 and 8 to identify the presence of p11. Oocytes 
were injected with either ENaC or ENaC+p11 and p11 protein level was compared after cell lysis using SDS-
PAGE and western blotting with anti-p11.  A) 5 oocytes from each group were lysed from week 7 and used 
to identify the presence of p11 in a western blot using a primary anti-p11 (rabbit source) antibody and an 
anti-mouse secondary antibody. The large smear covering the length of the gel in lanes 1 and 2 indicates 
non-specific binding of the antibody as we were expecting individual bands around 11 kDa in size. No 
protein presence in lanes 3 and 4. B) 5 oocytes from each group were lysed from week 8 and used to 
identify the presence of p11 in a western blot using a primary anti-p11 (rabbit source) antibody and an 
anti-rabbit secondary antibody. Aggregated smear between 18 and 7 kDa can be seen for lane 1 and 2, 
which could possibly be p11 however, it is present in both ENaC and ENaC + p11 samples, making it 











3.2- p11 knockdown 
3.2.1- p11 Knockdown Decreases Amiloride Sensitive Current. 
In order to further identify whether p11 is involved in ENaC trafficking, we investigated the 
effects of p11 knockdown on the amiloride sensitive current produced by ENaC in a model 
mammalian epithelium. The knockdown FRT cell culture was transfected with ENaC and p11-
siRNA compared to the control group, which was transfected with ENaC alone and a control si-
RNA. The cells were seeded on a Snap-well filter and the trans-epithelial current recorded using 
the Ussing chamber technique, with administration of amiloride effectively allowing us to 
compare the ENaC specific current for epithelia expressing ENaC in the presence of p11 
(endogenous), compared to epithelia expressing ENaC with a lack of p11 (knockdown).  
In order to achieve the knockdown in p11 expression, small interfering RNAs (siRNAs) were 
used. The siRNA is a double stranded RNA molecule which interferes with the translation of 
specific mRNAs post transcription (p11 in this case), by binding to its complimentary target and 
facilitating its cleavage via endonuclease (Hamilton & Baulcombe, 1999). FRT cells 
endogenously express p11 and hence require knockdown or silencing with a siRNA, allowing us 
to compare the effects of endogenous p11 on ENaC expression/ trafficking. 
To test how a decrease in p11 would affect the ENaC specific current/ amiloride sensitive 
current, Fisher Rat Thyroid (FRT) cells were used based on their ability to form an epithelium 
and express p11 endogenously. FRT cells were seeded on a Snap-well filter at a density of 4.5 x 
105 and transfected after 24 hours of incubation. FRTs on the filters were transfected with either 
ENaC + si-control or ENaC + p11-siRNA. The FRT culture was allowed to incubate post 




consequence of the knockdown, Ussing chamber recordings were conducted on the FRT 
epithelia. The Ussing chamber apparatus is composed of two independent chambers which 
separate the apical and basal sides of the epithelia. This apparatus allows us to measure the trans-
epithelial current and identify any amiloride sensitive current using application of amiloride to 
the apical bathing solution. 
Representative traces from the Ussing chamber recordings for ENaC + si-control (Figure 3.6. A) 
and ENaC + p11 (Figure 3.6. B) show a clear difference in the Isc-amiloride. The Isc-amiloride 
was observed to be larger for ENaC + si-control (0.31 mA) when compared to the knockdown 
group (0.07 mA). Furthermore, analysis of total Ussing chamber recordings (Figure 3.6. C) (n=9) 
identified, a significant decrease (average of 75%) (p=0.04) in the Isc-amiloride for ENaC + si-





Figure 3.6. Knockdown of p11 decreases amiloride sensitive current in Fischer Rat Thyroid epithelia. Representative 
trace (Ussing chamber) from FRT cells transfected on Snapells with ENaC + si-control (A) (0.067ng per subunit) compared to ENaC 
+ si-p11 (B) using lipofectamine 3000. 72 hours post transfection, FRT cells had formed a confluent polarized monolayer 
(epithelia) and their trans-epithelial current recorded using the Ussing chamber technique. 10 µL of amiloride (5 µM) was 
administered via the apical portion of the Ussing chamber with a pipetted. The characteristic drop in current identifies the Isc-
amiloride, with a larger drop, and hence ENaC population, seen in ENaC + si-control when compared to the knockdown group 
(ENaC + si-p11). (C) The amiloride sensitive current for all Ussing chamber recordings were normalised with respect to control 
(ENaC + si-control) experimetns from the same day. Statistical analysis of all viable (>300Ω/cm2) recordings from ENaC + si-control 
(n=5) compared to ENaC + si-p11 (n=4) found a significant decrease (average of 75%) in ENaC + si-p11 (p=0.04) compared to 






This result further supports the proposed hypothesis. The decreased Isc-amiloride in the ENaC + 
si-p11group is most likely due to reduced amounts of p11, as it was the only variable in the 
experiment.  
3.2.2- p11 is Expressed Endogenously in FRT Cells 
Having identified a significant difference in amiloride sensitive current due to the presence/ 
absence of p11, we wanted to verify whether p11 protein was knocked down within the FRTs 
cells as we hypothesized that the decrease in current that was seen in the Ussing chamber results 
was due to decreased p11, reducing exocytosis of ENaC. FRT cells were seeded at a density of 
4.5x105 onto 2 (plate A and B) culture plates and left for 24 hours in incubation. Post incubation, 
they were transfected with either control siRNA (20pmol) (A) or p11-siRNA (1 µL) (B). ENaC 
was omitted from transfections for western blots due to the purpose of the experiment focusing 
on the difference in p11 expression between control and knockdown in the FRT cultures. Cells 
were then allowed to incubate for 72 hours, after which they were lysed and equal quantities of 
proteins were loaded onto a 12% polyacrylamide gel for separation via electrophoresis. Once 
separated, the proteins were transferred onto a PVDF membrane. The membrane was blocked 
and incubated with an anti-p11 primary antibody and an anti-rabbit –HRP secondary antibody. 
Finally, the membrane was incubated in chemiluminescent reagent and exposed to photo reactive 
film and analysed. 
This experiment was carried out only once and the film was completely black with no bands able 
to be identified, classing the experiment as inconclusive. However, another McDonald lab 
member used the same FRT cells and antibody samples and showed significant knock down of 
p11 where the p11 knockdown sample had a smaller, fainter band, representing a decreased p11 




expression. This confirms that wild type FRT cells transfected with control siRNA, express 
endogenous p11 and that the p11-siRNA was successful in knocking down the p11 protein 






The epithelial sodium channel functions to reabsorb sodium from the filtrate, making it vital for 
sodium homeostasis and consequently blood pressure control (Masilamani et al, 1999). As a 
consequence of its importance in normal body function, any defects in the regulation of ENaC 
can result in inherited forms of hypo/ hypertension, as well as exacerbation of pathological 
diseases such as cystic fibrosis (CF) (Hanukoglu & Hanukoglu, 2016) (Mall et al, 2004). 
Regulation of ENaC requires synthesis and trafficking of the channel to and from the apical 
membrane, which involves multiple interacting proteins and organelles. The channel is regulated 
predominantly by hormones such as aldosterone and vasopressin, but also environmental 
influences such as pH (Konstas et al, 2000). Aldosterone and vasopressin upregulate ENaC 
activity by increasing the channel number and the open probability, but also by decreasing the 
rate of removal/ endocytosis from the cell surface (Masilamani et al, 1999; Flores et al, 2005). 
Relative to the developed understanding for endocytosis, there is a gap in the knowledge when it 
comes to understanding the pathway of ENaC trafficking to the cell membrane and the 
exocytosis of ENaC. Although we know that ENaC is made in the ER and transported to the 
Golgi for processing (modification of sugar chains, proteolytic cleavage) (Burns et al, 2007), the 
knowledge gap arises when it comes to understanding the mechanisms and proteins necessary for 
the trafficking of ENaC to the apical membrane. Hence, we proposed to identify potential 
proteins involved in the exocytic trafficking, and understand their functional relationship with 
ENaC. 
Not only will this help us understand more about exocytosis of ENaC, but will also aid in our 




sodium homeostasis, where defects in regulation lead to diseases and inherited forms of 
hypertension, this knowledge can be extended to serve as a paradigm to understanding more 
common forms of hypertension. 
4.1- Model for the regulation and exocytosis of ENaC 
Although it is known as to which pathways alter ENaC cell surface population (cAMP and 
SGK1) expression, many of the proteins involved in trafficking are still undetermined, with little 
knowledge about the mechanisms involved for trafficking to the cell surface. For example, there 
is uncertainty around vesicle dependent trafficking for ENaC. Research has shown ENaC present 
within vesicles, furthermore, showing that ENaC exocytosis is mediated by syntaxin and SNARE 
proteins (Duman & Forte, 2003). Contrary to this, studies have also shown that ENaC may 
undergo trafficking independent of vesicles, where other regulatory proteins may physically 
transport the channels to the apical surface (West & Blazer, 2005). 
As a solution, we proposed looking into proteins similar to ENaC, and their respective exocytic 
processes. Proteins such as CFTR and ASICs are also epithelial channels, but have an exocytic 
pathway which is far better described than ENaC. This allows for identification of specific 
proteins from the trafficking pathway and investigate whether they potentially interact with 
ENaC. An example of this is the S100A10 protein, also known as p11. P11 is a small protein 
from the S100 family and although S100 proteins are calcium dependent, amino acid changes in 
p11 make it calcium independent, and consequently, permanently active (Gerke & Weber, 1985). 
Previous research has identified p11’s involvement in facilitating the exocytic trafficking of 
epithelial channels, such as Nav1.8 and ASICs (Okuse et al, 2002; Donier et al, 2005). 
Therefore, p11 was determined as an appropriate target for research into the exocytic trafficking 




between ENaC and p11 (Cheung and McDonald, unpublished data), further supporting the 
hypothesis that p11 facilitates the exocytic trafficking of ENaC. The proposed function is 
illustrated in Figure 4.1 as a schematic. 
 
 
Although ENaC and p11 have been identified to interact, interaction mechanics are still 
unknown, and whether this interaction was for the purpose of exocytic trafficking had not been 
examined. Therefore, the aim of this project was to identify whether p11 has an effect on the 
exocytosis of ENaC. For this, the general outline of the experiment was subdivided into 2 
sections; effects of p11 overexpression and effects of p11 knockdown. Firstly, we used Xenopus 
Figure 4.1. Schematic illustrating the net positive effect when p11 is co-expressed with ENaC 
within a cell. (A) represents the presence of p11 (blue protein) within the cell (ENaC+p11), acting as a 
catalyst for the apical trafficking of ENaC (red channel) to the cell surface. The presence of p11 enables 
more channels to be trafficked via recruitment of multiple other trafficking proteins. (B) represents the cell 
model without the presence of p11 (ENaC alone), leading to a reduced number of channels being 




laevis oocytes for heterologous co-expression of ENaC and p11, comparing the difference in 
amiloride sensitive current (Isc-amiloride) for oocytes expressing ENaC alone or both ENaC and 
p11. In this scenario, the hypothesis was that p11 would increase trafficking and therefore 
increase amiloride sensitive current, and although the trend in results supported this, upon 
analysis, they were insignificant. 
Secondly, we looked at how a decrease in p11 protein expression would affect ENaC activity. 
Here, we used FRT cells for their endogenous p11 expression and epithelium forming properties. 
The FRT epithelia were divided into 2 groups; those transfected with ENaC and control siRNA 
and those transfected with both ENaC and p11 siRNA (to decrease p11 protein expression). 
There was a significant decrease in amiloride sensitive current in epithelia expressing ENaC + 
p11-siRNA compared to epithelia expressing ENaC + control-siRNA. 
4.2- Effect of p11 on ENaC current 
4.2.1- TEVC for p11 Overexpression 
Results from the overexpression of p11 showed that there was no significant difference when 
comparing ENaC alone and ENaC + p11 amiloride sensitive current. This contradicted the 
original hypothesis that p11 would increase the overall current, by facilitating the exocytosis of 
ENaC.  
Upon initial examination of the results from the first 4 weeks (0.75 ng ENaC, 0.75ng p11), 
results showed that, although a trend can be seen, in 3 out of 4 weeks of an increased amiloride 
sensitive current for intervention group (ENaC+p11), statistical analysis revealed insignificant 
differences between the two groups. A possibility here was that the amount of cRNA injected 




amiloride. This was tested by increasing the p11 concentration by 1 fold (1.50ng) while keeping 
ENaC constant (0.75ng). The experiments were repeated over another 4 weeks. However, results 
showed a similar trend to weeks 1-4. Although the difference in ASC was larger in weeks 5-8 
(17%) relative to weeks 1-4 (12%) (for ENaC+p11), analysis showed the results to be 
insignificant. There are further potential reasons as to why we got these results, such as the 
oocyte quality, Xenopus health and also human error in experimental procedures, which are most 
likely the cause of the insignificance.  
The results nullified our hypothesis and contradicted our expectations of p11 function, which 
were based, not only on p11’s established role in intracellular trafficking, but specifically due to 
its confirmed trafficking of epithelial plasma membrane receptor and channels. Furthermore, 
unpublished research from the Condliffe lab demonstrated that p11 does upregulate ENaC 
current (Condliffe, unpublished data). Research by Okuse et al. (2002) first identified p11 to 
interact independently with the tetrodotoxin-resistant sodium channel (Nav 1.8). Unlike most 
channels, Nav1.8 is poorly expressed within mammalian cell lines, however, when co-expressed 
with p11 within CHO-SNS22 cell line, there was an increase in the Nav1.8 expression and 
current (Okuse et al, 2002). P11 was also found to act as a regulatory factor which facilitates 
expression and promote the translocation of Nav1.8, increasing the sodium current. To further 
validate this, sensory neurons which express Nav1.8 endogenously were downregulated for p11 
expression using an antisense RNA strand strand (Okuse et al, 2002). This resulted in a decrease 
for Nav1.8 in sensory neurons, confirming that direct association of p11 is necessary for the 
apical translocation of the channel. Poon et al. (2004) went further than this, describing the 
binding sites on both p11 and Nav1.8, and also identifying, how p11 was specific to Nav1.8 and 




Furthermore, p11 has been shown to interact with the acid sensing ion channels (ASICs), 
specifically ASIC1a. ASICs are sodium channels, part of the same superfamily as ENaC, which 
is the ENaC/Degenerin superfamily (Waldmann et al, 1997). Donier et al. (2005) identified p11 
to physically interact with the N-terminal domain of ASIC1a. Co-expression within CHO-K1 
cells led to an increase in ASIC expression of 200% at the cell membrane, increasing overall 
peak currents. These were verified by membrane-associated immunoreactivity and also cell-
surface biotinylation (Donier et al, 2005). Due to this, the results generated from my 
overexpression experiments were unexpected, leading us to question what the possible downfalls 
could be. 
The insignificant nature of the results prevents us from concluding anything, however, we did 
find a trend in the results which suggested that p11 increases the amiloride sensitive current. 
Furthermore, unpublished data from the Condliffe lab repeated the experimental procedure and 
found that p11 does increase the ENaC current significantly, supporting the original hypothesis. 
Assuming the insignificance in our results was due to human error, this confirms the 
involvement on p11 in the apical trafficking of ENaC within a single cell.  
4.2.2- Ussing Chamber for p11 Knockdown 
As a continuation from the previous experiment, we wanted to validate if knockdown of p11 
would provide the appropriate reciprocation of the overexpression result. This portion of the 
experimental procedure was carried out using Fischer rat thyroid cell cultures for several reasons, 
including; FRT forms an epithelia, acting as a model for mammalian epithelia. Also, the 




The Fisher rat thyroid cell line is a stable thyroid cell line derived from the thyroid gland of 
Fischer rats. FRT cell cultures are able to form a polarized monolayer (epithelia) when grown on 
a specialized membrane filter and also endogenously express p11, due to this, the control group 
which was transfected with ENaC and control siRNA, contains an endogenous amount of p11, 
relative to the intervention group which was manipulated with a siRNA to reduce endogenous 
p11 synthesis. Since the only variable in this situation is p11 protein level, we can infer that any 
difference which is present between the control and intervention, must be due to changes in p11. 
Results from Ussing chamber recordings showed a decrease in the amiloride sensitive current for 
the FRT epithelia upon decrease (knockdown) of the p11 concentration. The decrease was 
statistically significant, supporting our original hypothesis. Reduction of p11 led to a decrease in 
Isc-amiloride, indicating a reduced ENaC population at the cell surface, hypothesized to be a 
consequence of reduced translocation to the apical membrane. Essentially, we are able to 
conclude that p11 plays a role in ENaC trafficking, in a way that the p11 concentration is 
proportional to the ENaC trafficking. Okuse et al. (2002) also found a similar result upon p11 
knockdown within dorsal root ganglion (DRG) neurons cells, reducing the sodium current 
through Nav1.8 sodium channels (Okuse et al, 2002). With our results for both overexpression 
and knockdown, together with supporting preliminary data from the Condliffe lab, we are able to 
conclude that p11 is involved in the trafficking of ENaC to the cell surface. This finding is 
further established with our results from the western blot which identified p11 protein level in 
the control and knockdown FRT cells. The reduced band intensity, found by Cheung & 
McDonald (unpublished data) for the knockdown sample indicates that the siRNA was 




4.2.3- Other potential reasons for current increase with p11 
As an aggregate, our results suggest it is possible to influence the ENaC activity/ sodium flow, 
by manipulation of the trafficking protein p11. The results demonstrate, to a certain degree, how 
we are able to manipulate the p11 concentration to bring about predictable responses in the 
apical population of ENaC.  
It is worth noting, that, due to p11’s role in trafficking of other epithelial channels, we assume 
that in our results, the increase in ENaC current is also due to increased trafficking (via p11 
facilitation), rather than other methods of increasing sodium current. It is possible that p11 
interacts with ENaC channels already resident at the cell membrane, and altering their activity by 
other means. This introduces multiple different factors which could potentially change the 
current model. Firstly, this raises the question as to whether p11 influences the open probability 
of ENaC. It is conceivable that p11 interacts with ENaC at the cell membrane to alter the gating 
and potentially increase the open probability of the channel, resulting with the observed increase 
in Isc-amiloride. Previous research by Borthwick et al. (2007) identified a similar function of 
p11 in relation to apical membrane chloride channels in epithelial membranes. The stimulation of 
cAMP levels within human bronchial epithelial cells lead to increased annexin A2-p11 complex 
formation with CFTR, leading to an increase in CFTR specific Cl--current (Borthwick et al, 
2007). This type of activation is cAMP dependent, which is also common to ENaC, when 
stimulated by vasopressin. Vasopressin is known to increase ENaC at the cell surface via 
trafficking of new channels to the membrane, by activation of the cAMP pathway (Snyder et al, 
2004; Butterworth et al, 2004). This is interesting because it provides a potential activating 
mechanism for the formation of the ENaC-p11 complex. Since this has been established within 




activation leads to ENaC-p11 complex formation would be to identify if p11 is truly upregulated 
within kidney collecting duct epithelial cells post vasopressin administration. A potential 
approach to this would be by utilization of the mCCD mouse renal collecting duct cell line 
recently gifted to the McDonald lab and application with vasopressin. Previous experiments have 
identified an increase in ENaC expression from vasopressin application, accompanied by an 
increase in cAMP levels (Snyder et al, 2004; Nicco et al, 2001). To further identify the effects on 
p11, a protein analysis consisting of SDS-PAGE and western blot could potentially identify an 
increase in p11 concentration in the kidneys of rats exposed to vasopressin compared to a 
control, or in the mCCD cell line. 
Alternatively, p11 could be functioning to prevent endocytosis of ENaC. There is a possibility 
that p11 interferes with the activity of Nedd4-2, which is a E3 ubiquitin ligase and ubiquitinates 
ENaC to promote endocytosis and degradation. Inhibition of Nedd4-2 activity by p11 would 
reduce ENaC endocytosis, increasing ENaC half-life at the cell membrane, resulting with an 
increased ENaC current, and in fact, mass spectroscopy results from the Condliffe lab 
(unpublished data) also identified binding of the ENaC-p11 complex to the RNF2 E3 ubiquitin 
ligase, therefore other ubiquitin ligases could be targeted by p11. Another way p11 may prevent 
endocytosis is via acting as a retention factor. Renigunta et al. (2006) demonstrated how p11 
binds to TASK-1 and causes retention within a membrane. This is due to a specific lysine based 
retention/ retrieval signal, where unbinding of p11 is required for transport post ER (Renigunta et 
al, 2006). Additionally, mass spectroscopy results from the Condliffe lab identified that the 
ENaC-p11 complex interacts with the COMMD10 protein (unpublished data). Research from the 
McDonald lab identified that COMMD10 plays a role in ENaC regulation, where stable 




prevent endocytosis of ENaC (Ware et al, manuscript under review). This further supports the 
idea that COMMD10 potentially interacts with the ENaC-p11 complex to reduce endocytosis 
and increase amiloride sensitive current. 
Lastly, p11 could be interacting with endocytic machinery to prevent ENaC translocation to the 
lysosome, but instead, diverting ENaC to the apical recycling endosome. In fact, Zobiack et al. 
(2003) found that p11 was implicated in the positioning of the recycling endosome, where it was 
able to determine the recycling endosome position. This could allow p11 to direct ENaC into the 
recycling endosome, rather than the lysosome, preventing degradation of ENaC (Zobiack et al, 
2003). Altogether, our results in conjunction with previous data can confirm that the ENaC-p11 
complex interacts with an array of proteins involved in ENaC trafficking to and from the apical 
membrane, therefore p11 could be regulating ENaC current through one or more of these 
pathways. 
4.2.4 ENaC and p11 interaction model 
From what has been established, previous data from the Condliffe and McDonald labs has shown 
that p11 and ENaC interact, and that p11 is involved in the exocytic trafficking of ENaC. 
However, how they interact, and the method of trafficking is still unknown. Research from Poon 
et al. (2004) showed that the binding position for p11 in relation to Nav1.8 was located on the N-
terminal domain, more specifically; amino acids 74-103 on Nav1.8 and residues 33-78 in p11 
(Poon et al, 2004). This is consistent with the ASIC-p11 complex, where ASIC1a was found to 
interact with p11 via its N terminal domain (Donier et al, 2005). From this, it can be postulated 
that the interaction site for p11 and ENaC may lie on the N terminal domain of the subunits, 





Furthermore, it has been shown that, as ENaC undergoes processing in the Golgi, it is cleaved by 
the protease Furin (Burns et al, 2007). The cleavage sites of Furin lie adjacent to the N terminal 
domain along each of the α, β and γ subunits, as seen in Figure 4.2 (Hughey et al, 2004).  
It is possible that proteolytic cleavage of ENaC is necessary for adequate p11 interaction, acting 
as a checkpoint mechanism, making sure only activated ENaC is allowed to be transported to the 
apical membrane. This proposition is further supported by research from Woodham et al. (2002), 
who identified that p11 interacts with the HPV capsid protein L2 post cleavage by Furin, which 
is present in the cell membrane (Woodham et al, 2012). Overall this indicates that it is highly 
likely that p11 interacts with ENaC post cleavage from the Golgi, and not before it, acting as a 
proponent for p11 as a trafficking protein rather than anything else. 
 
Another area of question includes the trafficking mechanism. Having established that ENaC and 
p11 form a complex, it is important to identify how the complex is transported to the apical 
membrane. Results from the mass spectroscopy from the Condliffe lab identified novel 
interactions of the ENaC-p11 complex with cytoskeletal components such as α and β-tubulin 
Figure 4.2. Schematic representing the α, β and γ-ENaC genes (SCNN1A, SCNN1G and 
SCNN1D). Indicated are the: Furin cleavage sites, M1, M2 domains, Ubiquitin binding sites and also the PY motif for 
Nedd4-2 binding for each ENaC subunit. Cleavage by Furin is carried out at the Golgi complex, essentially activating the 




(unpublished data). This hints at the involvement of p11 in the physical trafficking of ENaC to 
the surface and possible recruitment of other motor proteins. Regardless, it would be interesting 
to research this in the future where we identify how exactly p11 causes the trafficking of ENaC, 
and the motor proteins involved in the process. An approach to this would be by conducting a 
GST pull down assay to identify interactions between p11 and potential motor proteins, identical 




Initially, oocytes were used in the experiments looking at differences in ENaC expression. This 
is due to their large size, allowing for individual cell manipulation and also due to their known 
reliability in ENaC expression, as demonstrated by our experiments. Although expression is 
good, this does not represent an epithelial model, which is where ENaC is biologically 
expressed, hence why FRT cells were used for the knockdown experiment, as they form a 
polarized monolayer. This impacts the validity of our results due to the simple fact that oocytes 
are unlike most epithelia. It is also possible that the results for overexpression were confounded 
by the oocyte quality. Because oocytes were harvested from new Xenoupus each week, this 
introduced a high level of variability, with certain batches displaying healthier characteristics 
than others. It is highly likely that this influences the level and quality of protein expression 
within the oocytes, regardless of other variables. 
Furthermore, the inconsistency in the cell models used for overexpression compared to 




in ENaC expression, however, knockdown in oocytes requires one of two specific techniques 
which were unfamiliar to us in the laboratory (Zhu et al, 2015). To avoid further delays in the 
experiments, the knockdown was conducted within the FRT cell line, simply because it was 
familiar to us with successful previous experimentation using other siRNAs (Ke et al, 2010). 
This is an obvious limitation as it introduces large variability between the two experiments. 
Intracellularly, oocytes and FRT cells are highly variable with large differences in proteins and 
cellular machinery. This provides a high possibility that protein may interfere from one cell type, 
which are not present in the other. Future experiments for over- and underexpression should be 
conducted with the cell line as a constant in both experiments to avoid any confounding 
variability. 
On the other hand, FRT cells also provided limitations. Firstly, the cell line was used due to the 
advantage of endogenous p11 expression, however, the cells did not express ENaC and required 
transfection. Because ENaC was not endogenous, we are unable to state with confidence that the 
relationship observed in these results is reproducible within ENaC expressing epithelia. The FRT 
cells could be expressing other unidentified proteins with a confounding effect, hence, why the 
experiment should be carried out in vivo, preferably with mammalian epithelia such as rat distal 
colon or kidney collecting duct from mice over or underexpressing p11. 
Because the FRT cell line was passaged multiple times sequentially, this meant that each 
subsequent culture reduced in quality and quantity of current that could be measured. As the 
passage number increased, the growth rate was observed to decrease which affected the Ussing 
chamber recordings. This was often reflected as a reduction in trans-epithelial resistance, which, 
if below 300Ω/cm was disregarded from the results. This is because a resistance below 300Ω/cm 




rather than paracellular movement of Na+. This was diagnosed as an overall reduced cell number 
present when the FRT cells were seeded onto the Snapwell filter, and compensated for by 
increasing the seeding cell number from 4.0 x 105 to 4.5 x 105. 
A significant limitation was the antibodies used. Multiple attempts with the anti-p11 antibody 
resulted in negative and inconclusive results. The concentration of antibody required was 
difficult to approximate. Also, use of the mouse sourced anti-p11 continually resulted with 
negative and inconclusive results, as seen in the oocyte western blots. Due to this, a new rabbit 
sourced anti-p11 antibody was ordered. The delivery of the anti-body took several weeks, which 
delayed the p11 protein analysis for FRT cells. This prevented any repeats of the FRT p11 
knockdown western blots. 
 
4.4- Future Directions. 
Due to the fact that there was almost no previous knowledge around the interaction between p11 
and ENaC, this experiment, as a continuation of Steven Condliffe’s project, was essentially the 
first of its kind (to our knowledge). The results obtained are informative and promising, 
however, what this project clarified was a very small area with respect to the entire exocytic 
process for ENaC. Therefore, the results provide more questions than answers, advocating 
further research into this topic. 
Annexin A2 is a calcium binding protein which has been identified to form a heterotetrameric 
complex with p11 (A2-p11). The A2-p11 complex has been identified in many cellular process 
including trafficking of apical proteins such as CFTR and NKCC2 to the cell surface membrane.  




endogenously within the FRT cell line. This would be conducted by a simple western blot with 
antibodies specific to annexin A2. If confirmed, this could potentially explain the more 
significant nature of results obtained from the Ussing chamber recordings. Introducing the 
possibility that trafficking was further facilitated by the formation of A2-p11 complex’s rather 
than p11 individually.  
Due to the large number of proteins regulated by the A2-p11 complex (relative to p11 alone), it 
is much more likely that ENaC is regulated by the A2-p11 complex as well. To identify whether 
this is a possibility, annexin should be co-expressed with p11 and ENaC within oocytes. 
Although this will not replicate an epithelium, it allows us to identify whether there is a 
functional relationship present between the proteins. It is possible to identify if the annexin A2-
p11 complex contribute further to ENaC trafficking, by comparing the Isc-amiloride for ENaC + 
annexin A2-p11 to ENaC + p11. If the ASC for ENaC + A2-p11 are significantly larger than the 
ASC for ENaC + p11, this would provide evidence that in fact ENaC trafficking is facilitated by 
the A2-p11 complex, rather than p11 alone.  
Conversely, we could also carry out a knockdown for annexin A2 in FRT cells to identify the 
presence of endogenous annexin A2, which could be facilitating the ENaC trafficking by 
forming a complex with p11. Using an annexin A2 si-RNA to inhibit annexin expression within 
the FRT cells, and identify any differences in ENaC expression/ amiloride sensitive current, 
hypothesising, if annexin A2 is expressed endogenously, a respective decrease in amiloride 
sensitive current should be observed when annexin is knocked down. 
Preliminary mass spectroscopy data from the Condliffe lab identified other interacting proteins 
for the ENaC-p11 complex, including annexin A6. This is significant due to the role of annexin 




in regulation of ion channels and Ca2+ homeostasis, with a role in membrane organisation 
(Grewal et al, 2016). Although annexin A6 is slightly different to annexin A2, the study also 
found that mice with knockout of one or two of any annexin (annexin A1-A6) were viable and 
developed normally. This suggests an extent of redundancy within annexin function, where 
different annexins may act in a common way. If it is possible that annexin A2 and A6 play a 
similar role within the cell, it is likely that the interaction observed by the mass spectroscopy 
results indicate a functional relationship between annexins, p11 and ENaC, supporting the theory 
of an annexin-p11 complex facilitating ENaC transport. Furthermore, this would also support the 
annexin-p11 model proposed by Rescher & Gerke as seen in Figure 4.3, where p11 binds the 







Overall, the aim of this research project was to identify whether the trafficking protein p11 plays 
a role in facilitating the expression of ENaC. P11 had previously been identified in trafficking 
multiple other epithelial channels, with a confirmed interaction between p11 and ENaC 
confirmed by the Condiffe lab. Experiments of overexpression and knockdown of p11 were 
conducted in the presence of ENaC to find a functional consequence on ENaC expression. 
Cumulative results from my study and other studies in the Condliffe/McDonald labs confirm the 
role of p11 in ENaC function, where p11 facilitates an increase of ENaC current when present, 
supporting the proposed hypothesis. Due to the vital role of ENaC in sodium regulation and 
Figure 4.3. Schematic configurations of the Annexin A2 -p11 complex representing the two 
proposed methods of function. (A) both annexin A2 subunits bound to the same membrane surface while 
attached to p11 (S100A10). (B) preferential binding of annexin A2 to two different membranes. The affinity of 
annexin for plasma membrane is thought to originate from its ability to interact with negatively charged 
phospholipids in a calcium dependent manner (Gerke et al, 2005). Where annexin is proposed to bind membranes, 





hence, blood pressure regulation, any dysregulation in its activity can lead to forms of blood 
pressure dysfunctions (hyper/hypotension). Therefore, due to its implications in life shortening 
diseases, it is vital that we understand how the channel itself is regulated, including how it is 
transported to and from the membrane and what proteins assist in this pathway. The discovery of 
this functional interaction between ENaC and p11 could be beneficial in understanding how 
ENaC arrives to the apical surface, potentially allowing us to form future therapeutic approaches 
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